<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Contemp Oncol (Pozn)</journal-id><journal-id journal-id-type="iso-abbrev">Contemp Oncol (Pozn)</journal-id><journal-id journal-id-type="publisher-id">WO</journal-id><journal-title-group><journal-title>Contemporary Oncology</journal-title></journal-title-group><issn pub-type="ppub">1428-2526</issn><issn pub-type="epub">1897-4309</issn><publisher><publisher-name>Termedia Publishing House</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4322529</article-id><article-id pub-id-type="pmid">25691827</article-id><article-id pub-id-type="publisher-id">24048</article-id><article-id pub-id-type="doi">10.5114/wo.2014.47137</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Computational characterisation of cancer molecular profiles derived using next generation sequencing</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Oleksiewicz</surname><given-names>Urszula</given-names></name><xref ref-type="aff" rid="AF0001">1</xref><xref ref-type="aff" rid="AF0002">2</xref><xref ref-type="aff" rid="AF0007">*</xref></contrib><contrib contrib-type="author"><name><surname>Tomczak</surname><given-names>Katarzyna</given-names></name><xref ref-type="aff" rid="AF0001">1</xref><xref ref-type="aff" rid="AF0002">2</xref><xref ref-type="aff" rid="AF0003">3</xref><xref ref-type="aff" rid="AF0007">*</xref></contrib><contrib contrib-type="author"><name><surname>Woropaj</surname><given-names>Jakub</given-names></name><xref ref-type="aff" rid="AF0004">4</xref><xref ref-type="aff" rid="AF0007">*</xref></contrib><contrib contrib-type="author"><name><surname>Markowska</surname><given-names>Monika</given-names></name><xref ref-type="aff" rid="AF0005">5</xref></contrib><contrib contrib-type="author"><name><surname>St&#x00119;pniak</surname><given-names>Piotr</given-names></name><xref ref-type="aff" rid="AF0005">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Shah</surname><given-names>Parantu K</given-names></name><xref ref-type="aff" rid="AF0006">6</xref></contrib></contrib-group><aff id="AF0001"><label>1</label>Laboratory of Gene Therapy, Department of Cancer Immunology, The Greater Poland Cancer Centre, Poznan, Poland</aff><aff id="AF0002"><label>2</label>Department of Cancer Immunology and Diagnostics, Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland</aff><aff id="AF0003"><label>3</label>Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw</aff><aff id="AF0004"><label>4</label>Poznan University of Economics, Pozna&#x00144;, Poland</aff><aff id="AF0005"><label>5</label>Transition Technologies S.A., Warsaw, Poland</aff><aff id="AF0006"><label>6</label>Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA</aff><aff id="AF0007"><label>*</label>These authors contributed equally to this paper</aff><author-notes><corresp id="cor1"><bold>Address for correspondence: Parantu K. Shah</bold>, PhD, Institute for Applied Cancer Science, The UT MD Anderson Cancer Centre, Houston, TX 77030. phone: 713 794 4727. fax: 713 792 6882. e-mail: <email xlink:href="parantu.shah@gmail.com">parantu.shah@gmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>1</month><year>2015</year></pub-date><pub-date pub-type="ppub"><year>2015</year></pub-date><volume>19</volume><issue>1A</issue><fpage>A78</fpage><lpage>A91</lpage><permissions><copyright-statement>Copyright &#x000a9; 2015 Termedia</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Our current understanding of cancer genetics is grounded on the principle that cancer arises from a clone that has accumulated the requisite somatically acquired genetic aberrations, leading to the malignant transformation. It also results in aberrent of gene and protein expression. Next generation sequencing (NGS) or deep sequencing platforms are being used to create large catalogues of changes in copy numbers, mutations, structural variations, gene fusions, gene expression, and other types of information for cancer patients. However, inferring different types of biological changes from raw reads generated using the sequencing experiments is algorithmically and computationally challenging. In this article, we outline common steps for the quality control and processing of NGS data. We highlight the importance of accurate and application-specific alignment of these reads and the methodological steps and challenges in obtaining different types of information. We comment on the importance of integrating these data and building infrastructure to analyse it. We also provide exhaustive lists of available software to obtain information and point the readers to articles comparing software for deeper insight in specialised areas. We hope that the article will guide readers in choosing the right tools for analysing oncogenomic datasets.</p></abstract><kwd-group><kwd>next generation sequencing</kwd></kwd-group></article-meta></front><body><sec id="S0001"><title>Molecular profiling of cancer genomes</title><p>Over the years, individual laboratories and large-scale projects such as TCGA and ICGC have discovered that cancer is a heterogeneous disease with lots of variability within a single tumour type or even within a single tumour [<xref rid="CIT0001" ref-type="bibr">1</xref>&#x02013;<xref rid="CIT0004" ref-type="bibr">4</xref>]. Nonetheless, much of our current understanding of cancer genetics is grounded on the principle that cancer arises from a clone that has accumulated the requisite somatically acquired genetic aberrations leading to the malignant transformation [<xref rid="CIT0005" ref-type="bibr">5</xref>]. Characterising individual tumours or cohorts at the molecular level has helped in identifying common and type specific cancer vulnerabilities as well as recording the individual history of tumours [<xref rid="CIT0004" ref-type="bibr">4</xref>, <xref rid="CIT0006" ref-type="bibr">6</xref>&#x02013;<xref rid="CIT0008" ref-type="bibr">8</xref>]. This has enabled the creation of drugs that target these molecular vulnerabilities and provide tailored treatments for patients, improving therapy efficacy and minimising its side effects [<xref rid="CIT0009" ref-type="bibr">9</xref>, <xref rid="CIT0010" ref-type="bibr">10</xref>]. For example, Imatinib specifically targets the BCR-Abl fusion tyrosine kinase that exists only in the cells of chronic myelogenous leukaemia and other tumours but not in healthy cells [<xref rid="CIT0011" ref-type="bibr">11</xref>]. Similarly, Herceptin is a monoclonal antibody that is used to target HER2 positive breast tumours [<xref rid="CIT0012" ref-type="bibr">12</xref>].</p><p>At present, the TCGA and other large-scale projects characterise tumours with microarray and next generation sequencing (NGS) platforms to obtain a different type of genetic information at the whole genome level [<xref rid="CIT0006" ref-type="bibr">6</xref>&#x02013;<xref rid="CIT0008" ref-type="bibr">8</xref>, <xref rid="CIT0013" ref-type="bibr">13</xref>&#x02013;<xref rid="CIT0015" ref-type="bibr">15</xref>]. The microarray platform had been, and is currently being, used to identify gene and microRNA expression, alternative splicing, copy number alterations, DNA methylation, and identification of protein-DNA and protein-RNA interactions [<xref rid="CIT0016" ref-type="bibr">16</xref>]. Next generation sequencing platforms are now replacing the microarray platforms for obtaining these data. Moreover, sequence reads from whole exome sequencing, along with DNA and RNA sequencing, also allow detection of mutations and gene fusions for coding and non-coding regions of the genome [<xref rid="CIT0017" ref-type="bibr">17</xref>]. While conceptually similar in experiment design, the sequence read information generated using NGS platforms has very different statistical properties to intensity-based information acquired from microarray platforms [<xref rid="CIT0018" ref-type="bibr">18</xref>].</p><p>Multiple articles have reviewed protocols to generate microarray profiles and their statistical analysis to extract meaningful information [<xref rid="CIT0019" ref-type="bibr">19</xref>&#x02013;<xref rid="CIT0022" ref-type="bibr">22</xref>]. While relatively new, a vast amount literature describing statistical methodologies to analyse NGS data already exists [<xref rid="CIT0023" ref-type="bibr">23</xref>&#x02013;<xref rid="CIT0028" ref-type="bibr">28</xref>]. So, in this article we focus only on the methodologies to extract meaningful information from NGS reads. Moreover, we will discuss only those data types that are generated and analysed by TCGA. Furthermore, for each data type, we only describe the main steps to obtain this information and point the readers to an exhaustive list of methodologies/software and articles for deeper insight. Also, we do not provide any comments on comparison of these methods but rather point to articles comparing different methodologies and identifying their strengths and errors [<xref rid="CIT0029" ref-type="bibr">29</xref>&#x02013;<xref rid="CIT0032" ref-type="bibr">32</xref>].</p></sec><sec id="S0002"><title>Pre-processing and Quality Control of NGS data</title><p>To date, several next-generation sequencing platforms are available, including the Illumina Genome Analyser, which is being used extensively TCGA by consortium for tumour profiling. Each platform has its own method for generating sequencing reads from samples. But in every case, the sequence reads obtained using these platforms are short &#x02013; typically from 36 to several hundred nucleotides. Furthermore the sequencing run can be single-end or paired-end, meaning the reads are sequenced in one or two directions (from 3&#x02019; and 5&#x02019; ends). The first tasks in any NGS computational pipeline are: performing primary data acquisition, determining base calls and confidence scores from the fluorescent signals of the sequencer, and converting them to FASTQ files containing the raw sequence reads and per base quality scores. When multiple samples are pooled in one lane using sample-specific index/barcode adapters, the FASTQ should be demultiplexed and reorganised based on index information, and the adapters ought to be trimmed [<xref rid="CIT0033" ref-type="bibr">33</xref>].</p><p>Quality control is a very important part of the data preparation (<xref ref-type="table" rid="T0001">Table 1</xref>). There are several kinds of sequencing artefacts that could have a serious negative impact on downstream analyses. The artefacts commonly exist in raw reads, regardless of the sequencing platform. Firstly, sequences may be contaminated with adapters on their 5&#x02032;- or 3&#x02032; ends that were added as part of the sequencing protocol. Secondly, base quality and sequence complexity vary both within and between reads. The qualities of bases on most sequencing platforms will degrade as the run progresses, so it is common to see the quality of base calls falling towards the end of the read. It is desirable to remove or trim such sequences with appropriate thresholds. Additionally, NGS reads can be highly redundant with the same sequence being represented in large numbers, so it is important to reduce these PCR amplification artefacts. The contamination in the sequencing dataset can also be caused by laboratory factors such as sample preparation, library construction, and other steps of the experiment. Moreover, samples may contain DNA/RNA from other sources including viruses, which are hard to avoid during the sample preparation process. Finally, general statistical methods like sample clustering and principal component analysis (PCA), and outlier detection can be used for assessment of overall quality and sample comparison according to experiment design.</p><table-wrap id="T0001" position="float"><label>Table 1</label><caption><p>Software for primary quality control of NGS data</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Method name</th><th valign="top" align="center" rowspan="1" colspan="1">Year published</th><th valign="top" align="center" rowspan="1" colspan="1">PMID</th><th valign="top" align="center" rowspan="1" colspan="1">Data type</th><th valign="top" align="center" rowspan="1" colspan="1">Platform</th><th valign="top" align="center" rowspan="1" colspan="1">Statistical method</th><th valign="top" align="center" rowspan="1" colspan="1">Input requirements</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BIGpre</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">22289480</td><td align="center" rowspan="1" colspan="1">Illumina, 454</td><td align="center" rowspan="1" colspan="1">Perl</td><td align="left" rowspan="1" colspan="1">Correlation between forward and reverse reads, trimming low-quality reads</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">FastQC</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">any</td><td align="center" rowspan="1" colspan="1">Java</td><td align="left" rowspan="1" colspan="1">Sequence length, quality, k-mers presence reports</td><td align="center" rowspan="1" colspan="1">FASTQ, SAM/BAM</td></tr><tr><td align="left" rowspan="1" colspan="1">HTQC</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23363224</td><td align="center" rowspan="1" colspan="1">Illumina</td><td align="center" rowspan="1" colspan="1">C++</td><td align="left" rowspan="1" colspan="1">Tail trimming, filter by quality/length/tile</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">QC-Chain</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23565205</td><td align="center" rowspan="1" colspan="1">any</td><td align="center" rowspan="1" colspan="1">C++</td><td align="left" rowspan="1" colspan="1">Quality assessment, trimming, filtering unknown contamination</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">Qualimap</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22914218</td><td align="center" rowspan="1" colspan="1">any</td><td align="center" rowspan="1" colspan="1">Java, R</td><td align="left" rowspan="1" colspan="1">Alignment biases detection, sample comparison</td><td align="center" rowspan="1" colspan="1">SAM/BAM</td></tr><tr><td align="left" rowspan="1" colspan="1">PRINSEQ</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">21278185</td><td align="center" rowspan="1" colspan="1">any</td><td align="center" rowspan="1" colspan="1">Perl</td><td align="left" rowspan="1" colspan="1">Sequence complexity, duplicates, occurrence of Ns and poly-A/T tails, tag sequences reports</td><td align="center" rowspan="1" colspan="1">FASTQ, FASTA</td></tr><tr><td align="left" rowspan="1" colspan="1">PIQA</td><td align="center" rowspan="1" colspan="1">2009</td><td align="center" rowspan="1" colspan="1">19602525</td><td align="center" rowspan="1" colspan="1">Illumina</td><td align="center" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">Assess the clusters density per tile, base-calls proportions per tile/cycle</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">FastUniq</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">23284954</td><td align="center" rowspan="1" colspan="1">any</td><td align="center" rowspan="1" colspan="1">C++</td><td align="left" rowspan="1" colspan="1">De novo PCR duplicates removal for paired short reads</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr></tbody></table></table-wrap></sec><sec id="S0003"><title>Aligning short reads to the reference genome</title><p>Accurate alignment of short sequence reads generated using NGS platforms to a repeat masked reference genome is the first step in obtaining biological information from NGS data. Since, the numbers of reads generated in any given NGS experiment are very large (typically in millions), many efficient algorithms have been developed to deal with the alignment process. It is important to note that different read mapping procedures are necessary depending on the needs of downstream analysis, and alignment accuracy has a high impact on the interpretation of the data. We comment on that in sections to follow. Most applications aim to identify uniquely mapped reads - matching to a single &#x0201c;best&#x0201d; genomic position. The non-uniquely mapped reads are filtered using an upper boundary for the number of reported mappings.</p><p>Most short read alignment algorithms use auxiliary data structures (also called indexes) for the reads or reference sequence. The main indexing methods are based on hash tables, prefix/suffix trees, or merge sorting methods (<xref ref-type="table" rid="T0002">Table 2</xref>). Such representation of the entire human genome takes only a few GB of memory and enables exact matches to be found in a short time. Burrow-Wheeler transform and FM-index-based algorithms give better results for reads from repeated regions, but there is no efficient general method for handling errors in the reads for this category. Some hybrid solutions have been proposed, e.g. Stampy (see <xref ref-type="table" rid="T0002">Table 2</xref>). These enhancements result in higher sensitivity and smaller memory requirements of mapping tools. Reported mapping positions are particularly useful as they prevent the result list being blown up by reads mapping to highly repetitive regions. It is important to note that in the case of paired-end sequencing the paired reads need to be mapped to identical genomic positions to be considered multi-mapping reads. Data from Illumina's machine has few substitution errors per read and virtually no insertion or deletion (INDELs) errors [<xref rid="CIT0034" ref-type="bibr">34</xref>]. Thus, it can be mapped efficiently by, for example, Bowtie [<xref rid="CIT0035" ref-type="bibr">35</xref>], and then its junction-mapping extension can be done by Tophat [<xref rid="CIT0036" ref-type="bibr">36</xref>], which can handle up to three mismatches per sequence and no INDELs.
</p><table-wrap id="T0002" position="float"><label>Table 2</label><caption><p>Software for mapping sequence reads to genome</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Method name</th><th valign="top" align="center" rowspan="1" colspan="1">Year published</th><th valign="top" align="center" rowspan="1" colspan="1">PMID</th><th valign="top" align="center" rowspan="1" colspan="1">Data type</th><th valign="top" align="center" rowspan="1" colspan="1">Platform</th><th valign="top" align="center" rowspan="1" colspan="1">Statistical method</th><th valign="top" align="center" rowspan="1" colspan="1">Input requirements</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BFAST</td><td align="center" rowspan="1" colspan="1">2009</td><td align="center" rowspan="1" colspan="1">19907642</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">Based on creating flexible, efficient whole genome indexes to rapidly map reads to candidate alignment locations, with arbitrary multiple independent indexes allowed to achieve robustness against read errors and sequence variants.<break/>Final local alignment uses a Smith-Waterman method, with gaps to support the detection of small INDELs</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">Bowtie</td><td align="center" rowspan="1" colspan="1">2009</td><td align="center" rowspan="1" colspan="1">19261174</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C++ (SeqAn library)</td><td align="left" rowspan="1" colspan="1">Bowtie extends previous Burrows-Wheeler techniques with a novel quality-aware backtracking algorithm that permits mismatches</td><td align="center" rowspan="1" colspan="1">FASTQ, FASTA</td></tr><tr><td align="left" rowspan="1" colspan="1">BWA</td><td align="center" rowspan="1" colspan="1">2009</td><td align="center" rowspan="1" colspan="1">19451168</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">Backward search with Burrows-Wheeler Transform (BWT), allowing mismatches and gaps.</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">BWA-PSSM</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">24717095</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">Probabilistic adaptable alignment based on the use of position specific scoring matrices (PSSM) and BWT</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">CUSHAW2</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">22576173</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C++</td><td align="left" rowspan="1" colspan="1">Uses Burrows-Wheeler transform (BWT), the Ferragina-Manzini index and CUDA parallel programming model for GPUs. Supports only ungapped alignment</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">DistMap</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">24009693</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">Perl, Java</td><td align="left" rowspan="1" colspan="1">Wrapper for many aligners, based on MapReduc API for parallel processing. Currently not handling spliced alignments</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">MAQ</td><td align="center" rowspan="1" colspan="1">2008</td><td align="center" rowspan="1" colspan="1">18714091</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C++, Perl</td><td align="left" rowspan="1" colspan="1">Based on Smith-Waterman gapped alignment and Bayesian statistical model that incorporates the mapping qualities and error probabilities</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">MOSAIK</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">24599324</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C++</td><td align="left" rowspan="1" colspan="1">Uses hash clustering strategy coupled with the Smith-Waterman algorithm. Detects mismatches, short insertions and deletions</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">PASS</td><td align="center" rowspan="1" colspan="1">2009</td><td align="center" rowspan="1" colspan="1">19218350</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C++</td><td align="left" rowspan="1" colspan="1">Based on precomputed score tables (PST) calculated with the Needleman and Wunsch algorithm</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">RMAP</td><td align="center" rowspan="1" colspan="1">2009</td><td align="center" rowspan="1" colspan="1">19736251</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C++</td><td align="left" rowspan="1" colspan="1">Uses multiple filtration (Pevzner and Waterman) and approximate pattern matching.<break/>Incorporates the use of quality scores directly into the mapping process</td><td align="center" rowspan="1" colspan="1">FASTQ, FASTA</td></tr><tr><td align="left" rowspan="1" colspan="1">SOAPaligner/SOAP2</td><td align="center" rowspan="1" colspan="1">2009</td><td align="center" rowspan="1" colspan="1">19497933</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">Based on Burrows Wheeler Transformation (BWT) compression index</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">Stampy</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">20980556</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">Python</td><td align="left" rowspan="1" colspan="1">Hybrid probabilistic model for mapping quality (measured by Phred score)</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">ZOOM</td><td align="center" rowspan="1" colspan="1">2008</td><td align="center" rowspan="1" colspan="1">18684737</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Custom filtering model</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr></tbody></table></table-wrap><p>Transcriptome sequencing produces reads from transcribed sequences with introns and intergenic regions excluded. Standard alignment algorithms, which handle mismatches and gaps, generally do not handle mapping reads spanning across exons. Tools for identifying novel splice junctions usually use standard algorithms in the first step and then derive exon positions, e.g. from clustering of mapped reads or reads mapped into introns at their last few bases. Even in de novo assembly, in some parallel algorithms, if the location of each individual read is not tracked the reads may still need to be aligned back to the assembly. Therefore, sequence mapping is essential to almost all NGS techniques. Quantitation of microRNA expression requires similar steps but reads are mapped to the mature and precursor sequences of known miRNAs collected in microRNA databases. Prediction of secondary structure and genomic cluster analysis is useful [<xref rid="CIT0037" ref-type="bibr">37</xref>].</p></sec><sec id="S0004"><title>Expression quantitation and identification of differential expression</title><p>The expression level of each mRNA is measured by the number of sequenced fragments that map to the transcript (or counts and its derivatives), which is expected to correlate directly with its abundance level. Counts usually refer to the number of reads that align to a particular genomic feature. Like gene counts, any other targets may be quantified, including exons, transcripts, and miRNAs. Counts are heavily dependent on RNA sequencing depth and the effective length of the feature. Therefore, counts need to be adjusted for feature length to make the expression comparable. Effective gene counts are adjusted for the amount of bias in the experiment. Counts per million (CPM) mapped reads are counts scaled by the number of sequenced fragments multiplied by one million. CPM's length-normalised analogues are reads per kilobase per million (RPKM) and fragment per kilobase per million (FPKM). RPKM and FPKM are identical for single-end sequencing but differ for the paired-end sequencing. Calculating length-normalised measures makes them comparable within a sample. The RSEM package computes maximum likelihood abundance estimates using the Expectation-Maximisation algorithm and effectively takes care of multi-mapping reads. The RSEM representation is a current standard for reporting expression by Firehose GDAC pipeline.</p><p>A deficiency of the RPKM/FPKM approach is that the proportional representation of each gene is dependent on the expression levels of all other genes. Often a small fraction of genes account for large proportions of the sequenced reads, and small expression changes in these highly expressed genes will skew the counts of lowly expressed genes under this scheme. This can result in deduction of erroneous differential expression. Therefore, methods for calculating differential expression require counts to begin with. Thus RNA-Seq non-negative counts follow discrete distribution as opposed to the intensities recorded from microarrays, which are treated as continuous measurements and commonly assumed to follow a log-normal distribution. For RNA-Seq data Poisson distribution and Negative Binomial (NB) distribution are the two most commonly used models [<xref rid="CIT0038" ref-type="bibr">38</xref>&#x02013;<xref rid="CIT0042" ref-type="bibr">42</xref>] (<xref ref-type="table" rid="T0003">Table 3</xref>). Other distributions, such as beta-binomial [<xref rid="CIT0043" ref-type="bibr">43</xref>], have also been proposed.</p><table-wrap id="T0003" position="float"><label>Table 3</label><caption><p>Software for RNA-Seq data analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Method name</th><th valign="top" align="center" rowspan="1" colspan="1">Year published</th><th valign="top" align="center" rowspan="1" colspan="1">PMID</th><th valign="top" align="center" rowspan="1" colspan="1">Data type</th><th valign="top" align="center" rowspan="1" colspan="1">Platform</th><th valign="top" align="center" rowspan="1" colspan="1">Statistical method</th><th valign="top" align="center" rowspan="1" colspan="1">Input requirements</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Aldex</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23843979</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">ANOVA, Dirichlet distribution</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">ALDEx2</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">24910773</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Dirichlet distribution, glm</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">ASC</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">21080965</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Empirical Bayes,</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">baySeq</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">20698981</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Empirical Bayes</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">BBSeq</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">21810900</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Beta-Binomial, linear model</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">CEDER</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22641709</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Negative binomial</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">campcodeR (uses edgeR &#x00026; DESeq)</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">24813215</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Empirical Bayes</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">COV2HTML (not working)</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">24512253</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">Web site</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CPTRA</td><td align="center" rowspan="1" colspan="1">2009</td><td align="center" rowspan="1" colspan="1">19811681</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">Python</td><td align="center" rowspan="1" colspan="1">???</td><td align="center" rowspan="1" colspan="1">Long-read sequence w/ annotation, short-read sequence tag // fasta, fastq</td></tr><tr><td align="left" rowspan="1" colspan="1">CQN</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22285995</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Conditional quantile normalisation, robust generalised regression</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">Cuffdiff</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23222703</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">Standalone</td><td align="center" rowspan="1" colspan="1">Beta negative binomial distribution</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">DegPack</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">24981075</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">Web site</td><td align="center" rowspan="1" colspan="1">Non-parametric (ranks)</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">DEGseq</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">19855105</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">MA-plot-based (?)</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">DER Finder</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">24398039</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Hidden Markov Model</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">DESeq</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">20979621</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Negative binomial distribution</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">DEXUS</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">24049071</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Expectation-maximisation algorithm, Bayes</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">EBSeq</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23428641</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Empirical Bayes</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">EDASeq (users edgeR &#x00026; DESeq)</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">22177264</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Empirical Bayes</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">edgeR</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22287627</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Empirical Bayes, glm</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">edgeR-robust</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">24753412</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Weights, empirical Bayes</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">GExposer</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Machine learning algorithm</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">iFad</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22581178</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Bayesian sparse factor model</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">MRFSEQ (uses DESeq)</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23793751</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">Standalone</td><td align="center" rowspan="1" colspan="1">Markov random field model</td><td align="center" rowspan="1" colspan="1">Raw counts, co-expression database</td></tr><tr><td align="left" rowspan="1" colspan="1">Myrna</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">20701754</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">Cloud-computing, Bowtie, R</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">NOISeq</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">21903743</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Non-parametric</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">NPEBseq</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23981227</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Non-parametric Bayesian</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">pairedBayes</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Empirical Bayes</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">PoissonSeq</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22003245</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Poisson goodness-of-fit</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">QuasiSeq</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">23104842</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Quasi-Poisson, quasi-negative binomial</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">RNASeqGUI (uses edgeR, DESeq, NoiSeq, BaySeq)</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">24812338</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Empirical Bayes, negative binomial</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">SAMSeq</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">22127579</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">Standalone</td><td align="center" rowspan="1" colspan="1">Non-parametric</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">ShrinkBaye</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">24766777</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Negative binomial, Poisson-Gaussian, Bayesian GLM</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">sSeq</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23589650</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Negative Binomial</td><td align="center" rowspan="1" colspan="1">Raw Counts</td></tr><tr><td align="left" rowspan="1" colspan="1">TCC (uses edgeR, DESeq, DESeq2)</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23837715</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Negative Binomial, Empirical Bayes</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">tRanslatome</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">24222209</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Rank Product, t-test, SAM, limma, ANOTA, DESeq, edgeR</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr><tr><td align="left" rowspan="1" colspan="1">TSPM.R</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">tweeDEseq</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23965047</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">Poisson-Tweedie distributions</td><td align="center" rowspan="1" colspan="1">Raw counts</td></tr></tbody></table></table-wrap><p>The Poisson distribution has the advantage of simplicity and has only one parameter, but it constrains the variance of the modelled variable to be equal to the mean. The Negative Binomial distribution has two parameters, encoding the mean and the dispersion, and hence allows modelling of more general mean-variance relationships. For RNA-seq, it has been suggested that the Poisson distribution is well suited for analysis of technical replicates, whereas the higher variability between biological replicates necessitates a distribution incorporating overdispersion, such as Negative Binomial [<xref rid="CIT0028" ref-type="bibr">28</xref>, <xref rid="CIT0044" ref-type="bibr">44</xref>, <xref rid="CIT0045" ref-type="bibr">45</xref>]. Analogous to microarray data analysis, it is clear that borrowing the variance from other genes help to better estimate the variation in read counts for a gene and condition. This overcomes a common problem with an underestimation of variance when based on a low number of observations. The most commonly used parametric methods include EdgeR, DESeq, and baySeq and use negative binomial distribution. Other methods such as Cuffdiff2 uses a beta-negative binomial distribution, which is a combination of beta and negative binomial distribution. Non-parametric methods like SAM-Seq also work relatively well on the count data.</p></sec><sec id="S0005"><title>Identification of alternative splicing from transcriptomic reads</title><p>A widely recognised source of proteome diversity in eukaryotic species is expression of multiple distinct mRNA transcripts from a single gene locus by alternative transcript initiation, alternative splicing [<xref rid="CIT0047" ref-type="bibr">47</xref>] (<xref ref-type="table" rid="T0004">Table 4</xref>), and alternative polyadenylation [<xref rid="CIT0048" ref-type="bibr">48</xref>]. If RNA-Seq reads span exon junctions, parts of reads will map to two different exons. This allows inference of alternative splicing. However, such a read structure will pose problems to standard aligners that map reads contiguously to the reference. Splice sites can be detected initially by identifying reads that span exon junctions. Split-read aligners such as TopHat, methods that identify minimal match on either side of exon junction, and genomic short-read nucleotide alignment are used to identify alternative splicing. Most methods utilise a database of expression and alternative expression sequence &#x02018;features&#x02019;. These and other strategies that perform de-novo assemblies present a number of computational challenges because of computation time and the depth of sequencing, which results in few junction-spanning reads. This quantitation of alternatively spliced transcripts needs to be followed by identification of differential expression of these transcripts between samples.</p><table-wrap id="T0004" position="float"><label>Table 4</label><caption><p>Alternative splicing algorithm</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Method name</th><th valign="top" align="center" rowspan="1" colspan="1">Year published</th><th valign="top" align="center" rowspan="1" colspan="1">PMID</th><th valign="top" align="center" rowspan="1" colspan="1">Data type</th><th valign="top" align="center" rowspan="1" colspan="1">Platform</th><th valign="top" align="center" rowspan="1" colspan="1">Statistical method</th><th valign="top" align="center" rowspan="1" colspan="1">Input requirements</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ABMapper</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">21169377</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C++, Perl</td><td align="left" rowspan="1" colspan="1">Fast suffix-array algorithm and a dual-seed strategy for spliced alignment</td><td align="center" rowspan="1" colspan="1">FASTA, FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">ERANGE</td><td align="center" rowspan="1" colspan="1">2008</td><td align="center" rowspan="1" colspan="1">18516045</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">Python</td><td align="left" rowspan="1" colspan="1">Splice junctions identification relies on reference genome exon positions</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">GEM Mapper</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">23103880</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C, Objective Caml</td><td align="left" rowspan="1" colspan="1">Based on Burrows-Wheeler Transform and custom mapping algorithms. Uses custom mappability concept</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">MapSplice</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">20802226</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C++, Python</td><td align="left" rowspan="1" colspan="1">Algorithm not dependent on splice site features or intron length; consequently, it can detect novel canonical as well as non-canonical splices. This method has tag alignment phase and splice inference phase</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">PALMapper</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">21154708</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">Web/ Galaxy</td><td align="left" rowspan="1" colspan="1">Combines GenomeMapper (based on BWT and k-mer indexes) read mapper with the spliced aligner QPALMA</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">QPALMA</td><td align="center" rowspan="1" colspan="1">2008</td><td align="center" rowspan="1" colspan="1">18689821</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C++, Python</td><td align="left" rowspan="1" colspan="1">SVM-based splice site predictor with the so-called &#x02018;weighted degree&#x02019; kernel. Alignment based on extended BWT</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">SpliceMap</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">20371516</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C++, Python</td><td align="left" rowspan="1" colspan="1">Cannoical GT-AG splice sites identification using half-read mapping</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">SplitSeek</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">20236510</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Candidate junction reads generation in intermediate BEDPE format feasible for paired-end sequences</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">Subread</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23558742</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">Seed-and-vote - new multi-seed alignment strategy for overlapping seeds from each read (subreads)</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">TopHat</td><td align="center" rowspan="1" colspan="1">2009</td><td align="center" rowspan="1" colspan="1">19289445</td><td align="center" rowspan="1" colspan="1">RNA</td><td align="center" rowspan="1" colspan="1">C++</td><td align="left" rowspan="1" colspan="1">Canonical GT&#x02013;AG splice sites identification</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr></tbody></table></table-wrap><p>Apart from detection and quantitation of expression and alternative splicing, RNAseq has the capacity to identify RNA editing events [<xref rid="CIT0049" ref-type="bibr">49</xref>&#x02013;<xref rid="CIT0051" ref-type="bibr">51</xref>], allele-specific expression (ASE) [<xref rid="CIT0052" ref-type="bibr">52</xref>, <xref rid="CIT0053" ref-type="bibr">53</xref>], quantify noncoding RNAs [<xref rid="CIT0054" ref-type="bibr">54</xref>, <xref rid="CIT0055" ref-type="bibr">55</xref>], and detect exogenous RNA [<xref rid="CIT0056" ref-type="bibr">56</xref>, <xref rid="CIT0057" ref-type="bibr">57</xref>], single-nucleotide polymorphisms (SNPs), somatic mutations [<xref rid="CIT0008" ref-type="bibr">8</xref>, <xref rid="CIT0058" ref-type="bibr">58</xref>], and structural variations.</p></sec><sec id="S0006"><title>Detection of somatic copy number alterations and structural variants</title><p>Genomic alterations accumulate in tumours during cancer development [<xref rid="CIT0059" ref-type="bibr">59</xref>]. In addition to point-mutations, inversions, and translocations, somatic copy-number alterations (SCNAs) are ubiquitous in cancer [<xref rid="CIT0060" ref-type="bibr">60</xref>, <xref rid="CIT0061" ref-type="bibr">61</xref>], and several recurrent SCNAs are associated with particular cancer types [<xref rid="CIT0062" ref-type="bibr">62</xref>], tumour aggressiveness [<xref rid="CIT0063" ref-type="bibr">63</xref>], and patient prognosis [<xref rid="CIT0064" ref-type="bibr">64</xref>]. Reliable detection of SCNAs can lead to identification of cancer driver genes [<xref rid="CIT0065" ref-type="bibr">65</xref>] and development of new therapeutic approaches [<xref rid="CIT0066" ref-type="bibr">66</xref>&#x02013;<xref rid="CIT0068" ref-type="bibr">68</xref>]. Deep sequencing [<xref rid="CIT0069" ref-type="bibr">69</xref>] and exome-based sequencing efforts are now replacing microarray-based array CGH (aCGH) [<xref rid="CIT0070" ref-type="bibr">70</xref>] and single nucleotide polymorphism arrays (SNP arrays) [<xref rid="CIT0023" ref-type="bibr">23</xref>, <xref rid="CIT0071" ref-type="bibr">71</xref>]. Moreever, similarly to microarray-based studies, the inference about cancer related copy number alterations requires comparison of paired samples &#x02013; normal and tumour.</p><p>The general workflow to detect SCNAs from sequencing data consists of three main steps: (i) raw copy-number inference in the local genome region by either calculating read counts or depth of coverage ratio between tumour and control samples, (ii) the raw copy-number profiles segmentation to find change-points in the raw copy-number signal and divide the chromosomes accordingly into segments with similar copy-numbers, and (iii) classification of different segments into gains or losses. The first step is essentially based on understanding variations in depth of coverage (DOC) of aligned sequence reads against the reference genome [<xref rid="CIT0069" ref-type="bibr">69</xref>, <xref rid="CIT0072" ref-type="bibr">72</xref>, <xref rid="CIT0073" ref-type="bibr">73</xref>]. Deviation from the background in DOC may signify the presence of a copy number variation (CNV). The last two steps for obtaining copy number alteration are not specific to the sequencing data.</p><p>Multiple methods exist for identification of structural variations using whole genome sequencing. Methods include identification of atypical alignment patterns of sequence reads against the reference genome, which reflect gaps in the sequence alignment [<xref rid="CIT0074" ref-type="bibr">74</xref>]. In paired-end read mapping, the sequenced ends of a short DNA fragment are aligned against the reference genome. The mean insert size of the fragment is compared with the reference genome distance between aligned fragment ends to deduce the presence of deletions or insertions [<xref rid="CIT0074" ref-type="bibr">74</xref>&#x02013;<xref rid="CIT0076" ref-type="bibr">76</xref>]. This detection requires high alignment accuracy and underscores its importance.</p><p>Although coding regions comprise only &#x0223c;1% of the genome, they are enriched for causal variation, making exome-based studies valuable, manageable, and cost-effective. Whole exome sequencing (WES) data have been used effectively for the identification of small INDELs, usually of a size &#x0003c; 50 bp, within exon targets that are typically sized between 200 and 300 bp. The approaches discussed above, while appropriate for (deeply sequenced) DNA-sequencing data, are less effective for exome sequencing and detecting CNV, as the CNV's breakpoints are likely to lie outside the targeted exons [<xref rid="CIT0077" ref-type="bibr">77</xref>]. Detecting structural and copy number variations from RNA-Seq data presents similar challenges.</p></sec><sec id="S0007"><title>Identification of cancer driver mutations and their functional impact</title><p>Cancer is abundantly composed of somatic mutations accumulating in the genome over an individual's lifetime, only a fraction of which drive cancer progression. Mutations can be identified from DNA-seq, RNA-seq, and Exome sequencing data [<xref rid="CIT0078" ref-type="bibr">78</xref>&#x02013;<xref rid="CIT0080" ref-type="bibr">80</xref>] (<xref ref-type="table" rid="T0005">Table 5</xref>). The most basic way of detecting somatic mutations from NGS reads is to identify mismatch/gaps in the alignment of the read with the reference. However, large datasets possess sequencing errors: random mutations that occur during cell division and single nucleotide polymorphisms that differ from reference assembly. This makes identification of cancer driver mutations a challenging issue [<xref rid="CIT0081" ref-type="bibr">81</xref>]. Moreover, intra-tumour heterogeneity also hinders the identification of all types of somatic mutations [<xref rid="CIT0082" ref-type="bibr">82</xref>]. Several methods for detecting somatic mutations are currently in use, such as MuTect [<xref rid="CIT0083" ref-type="bibr">83</xref>], Strelka [<xref rid="CIT0084" ref-type="bibr">84</xref>], and VarScan 2 [<xref rid="CIT0085" ref-type="bibr">85</xref>] for SNV detection or BIC-Seq [<xref rid="CIT0086" ref-type="bibr">86</xref>], APOLLOH [<xref rid="CIT0087" ref-type="bibr">87</xref>], CoNIEFER [<xref rid="CIT0088" ref-type="bibr">88</xref>], BreakDancer [<xref rid="CIT0089" ref-type="bibr">89</xref>], and Meerkat [<xref rid="CIT0087" ref-type="bibr">87</xref>] for CNA or SV detection. Most methods for somatic mutation detection take into account only part of the possible source of errors; therefore, running different methods simultaneously is advisable.</p><table-wrap id="T0005" position="float"><label>Table 5</label><caption><p>Methods for finding mutations</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Method name</th><th valign="top" align="center" rowspan="1" colspan="1">Year published</th><th valign="top" align="center" rowspan="1" colspan="1">PMID</th><th valign="top" align="center" rowspan="1" colspan="1">Data type</th><th valign="top" align="center" rowspan="1" colspan="1">Platform</th><th valign="top" align="center" rowspan="1" colspan="1">Statistical method</th><th valign="top" align="center" rowspan="1" colspan="1">Input requirements</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ActiveDriver</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23340843</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">Generalized linear regression</td><td align="center" rowspan="1" colspan="1">FASTA, TAB</td></tr><tr><td align="left" rowspan="1" colspan="1">CancerMutationAnalysis</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">24233780</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">Empirical Bayes</td><td align="center" rowspan="1" colspan="1">Non-standard tables</td></tr><tr><td align="left" rowspan="1" colspan="1">CanDrA</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">24205039</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Perl</td><td align="left" rowspan="1" colspan="1">U-Mann Whitney, AUC (area under curve)</td><td align="center" rowspan="1" colspan="1">Non-standard tables</td></tr><tr><td align="left" rowspan="1" colspan="1">CanPredict</td><td align="center" rowspan="1" colspan="1">2007</td><td align="center" rowspan="1" colspan="1">17537827</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Web site</td><td align="left" rowspan="1" colspan="1">SIFT, Pfam-based logR.E-value metric, GOSS</td><td align="center" rowspan="1" colspan="1">FASTA</td></tr><tr><td align="left" rowspan="1" colspan="1">CAROL</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22261837</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">SIFT, PolyPhen-2</td><td align="center" rowspan="1" colspan="1">Tab-delimited, FASTA</td></tr><tr><td align="left" rowspan="1" colspan="1">CHASM/SNV-Box</td><td align="center" rowspan="1" colspan="1">2009</td><td align="center" rowspan="1" colspan="1">19654296</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Standalone</td><td align="left" rowspan="1" colspan="1">CHASM, SNV-Box</td><td align="center" rowspan="1" colspan="1">dnSNP r#, Pubmed ID, VCF, bed,</td></tr><tr><td align="left" rowspan="1" colspan="1">CRAVAT</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23325621</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Web site</td><td align="left" rowspan="1" colspan="1">CHASM, SnvGet</td><td align="center" rowspan="1" colspan="1">Non-standard tables</td></tr><tr><td align="left" rowspan="1" colspan="1">DDIG-in</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23497682</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Web site</td><td align="left" rowspan="1" colspan="1">Support vector machine-based method</td><td align="center" rowspan="1" colspan="1">Non-standard tables</td></tr><tr><td align="left" rowspan="1" colspan="1">DMI</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">23044540</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Standalone</td><td align="left" rowspan="1" colspan="1">Machine learning, discrimination index</td><td align="center" rowspan="1" colspan="1">Text file</td></tr><tr><td align="left" rowspan="1" colspan="1">DrGaP</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23954162</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Standalone</td><td align="left" rowspan="1" colspan="1">Chi-square distribution</td><td align="center" rowspan="1" colspan="1">Non-standard tables</td></tr><tr><td align="left" rowspan="1" colspan="1">e-Driver</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">25064568</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Perl</td><td align="left" rowspan="1" colspan="1">Binomial distribution</td><td align="center" rowspan="1" colspan="1">Non-standard tables</td></tr><tr><td align="left" rowspan="1" colspan="1">eXtasy</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">24076761</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Web site</td><td align="left" rowspan="1" colspan="1">Variant impact prediction, haploinsufficiency prediction, phenotype-specific gene prioritisation</td><td align="center" rowspan="1" colspan="1">VCF</td></tr><tr><td align="left" rowspan="1" colspan="1">FATHMM</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23620363</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Web site</td><td align="left" rowspan="1" colspan="1">Hidden Markov Model</td><td align="center" rowspan="1" colspan="1">Annotated VCF</td></tr><tr><td align="left" rowspan="1" colspan="1">InVEx</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22817889</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Python</td><td align="left" rowspan="1" colspan="1">Permutation-based</td><td align="center" rowspan="1" colspan="1">Non-standard tables, power FASTA</td></tr><tr><td align="left" rowspan="1" colspan="1">MuSIC</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22759861</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Standalone</td><td align="left" rowspan="1" colspan="1">Fisher p-value, likelihood ratio test, convolution test (summarised log statistic of joint binomial point probability)</td><td align="center" rowspan="1" colspan="1">BAM, SNV, MAF</td></tr><tr><td align="left" rowspan="1" colspan="1">MutSig</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23770567</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Standalone</td><td align="left" rowspan="1" colspan="1">MutSigCV (Background mutation rate)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">nsSNPAnalyzer</td><td align="center" rowspan="1" colspan="1">2005</td><td align="center" rowspan="1" colspan="1">15980516</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Web site</td><td align="left" rowspan="1" colspan="1">Machine learning (random forest)</td><td align="center" rowspan="1" colspan="1">FASTA, SNP</td></tr><tr><td align="left" rowspan="1" colspan="1">Oncodrive-fm</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22904074</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Standalone</td><td align="left" rowspan="1" colspan="1">SIFT, PolyPhen2, MutationAssessor</td><td align="center" rowspan="1" colspan="1">TDM, TSV</td></tr><tr><td align="left" rowspan="1" colspan="1">OncodriveCLUST</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23884480</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Python</td><td align="left" rowspan="1" colspan="1">Clustering</td><td align="center" rowspan="1" colspan="1">Non-standard tables</td></tr><tr><td align="left" rowspan="1" colspan="1">PANTHER</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23193289</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Web site</td><td align="left" rowspan="1" colspan="1">subPSEC</td><td align="center" rowspan="1" colspan="1">FASTA</td></tr><tr><td align="left" rowspan="1" colspan="1">PhD-SNP</td><td align="center" rowspan="1" colspan="1">2006</td><td align="center" rowspan="1" colspan="1">16895930</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Web site</td><td align="left" rowspan="1" colspan="1">Sequence and Profile-Based</td><td align="center" rowspan="1" colspan="1">FASTA</td></tr><tr><td align="left" rowspan="1" colspan="1">PROVEAN</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">23056405</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Standalone</td><td align="left" rowspan="1" colspan="1">Alignment-Based</td><td align="center" rowspan="1" colspan="1">Non-standard tables</td></tr><tr><td align="left" rowspan="1" colspan="1">transFIC</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">23181723</td><td align="center" rowspan="1" colspan="1">DNA-seq</td><td align="center" rowspan="1" colspan="1">Web site</td><td align="left" rowspan="1" colspan="1">SIFT, PolyPhen2, MutationAssessor</td><td align="center" rowspan="1" colspan="1">File w/ chromosome/protein coordinates (hg19)</td></tr></tbody></table></table-wrap><p>The most basic task for mutation analysis in cancer is the distinction between driver and passenger mutations. To help filter a subset of driver mutations from the long list of detected somatic and passenger mutations, three major computational predictive approaches utilising different statistical tests can be applied [<xref rid="CIT0090" ref-type="bibr">90</xref>&#x02013;<xref rid="CIT0092" ref-type="bibr">92</xref>]:</p><p>(1) <bold>Identification of recurrent somatic mutations</bold> is based on the idea of clonal evolution of tumour cell populations. To predict genes with recurrent single-mutations in a cohort of cancer patients, several statistical methodologies including MutSigCV [<xref rid="CIT0003" ref-type="bibr">3</xref>], MuSiC [<xref rid="CIT0093" ref-type="bibr">93</xref>], and DrGaP [<xref rid="CIT0094" ref-type="bibr">94</xref>] are available. These methods are based on the determination of the probability of the observed number of mutations in a gene to the expected background mutation rate, the BMR (probability of observed passenger mutation) across a cohort of patients. As opposed to mutations, there is no accurate model established to identify genes with recurrent copy number aberrations (CNAs); therefore, methods are based on a non-parametric approach, e.g. GISTIC2 [<xref rid="CIT0095" ref-type="bibr">95</xref>], CMDS [<xref rid="CIT0096" ref-type="bibr">96</xref>], and ADMIRE [<xref rid="CIT0097" ref-type="bibr">97</xref>].</p><p>(2) <bold>Prediction of the functional impact of individual mutations</bold> is based on the utilisation of additional information about protein sequence and/or structure and evolutionary conservation of the protein encoded by the mutated gene. Methods like SIFT [<xref rid="CIT0098" ref-type="bibr">98</xref>], Polyphen-2 [<xref rid="CIT0099" ref-type="bibr">99</xref>], and MutationAssesor [<xref rid="CIT0100" ref-type="bibr">100</xref>] predict the functional impact (deleteriousness) of missense mutations. CHASM utilises random forest classification to identify driver and passenger somatic missense mutations, based on a training set of labelled positive (driver) and negative (passenger) examples [<xref rid="CIT0101" ref-type="bibr">101</xref>]. Furthermore, clusters of non-synonymous mutations across patients, typically to detect &#x02018;activating&#x02019; mutations, NMC [<xref rid="CIT0102" ref-type="bibr">102</xref>] and the Invex [<xref rid="CIT0103" ref-type="bibr">103</xref>] method can be applied. Moreover, the iPAC method is able to search for clusters of mutations, but in the context of crystal structures of proteins [<xref rid="CIT0104" ref-type="bibr">104</xref>].</p><p>(3) <bold>Identification of recurrent combinations of mutations</bold> is based on assessment of combinations of mutations enriched in known pathways (e.g. GSEA [<xref rid="CIT0105" ref-type="bibr">105</xref>], Path-Scan [<xref rid="CIT0106" ref-type="bibr">106</xref>], Patient-oriented gene sets [<xref rid="CIT0107" ref-type="bibr">107</xref>]), interaction networks (NetBox [<xref rid="CIT0108" ref-type="bibr">108</xref>], HotNet [<xref rid="CIT0109" ref-type="bibr">109</xref>], MEMo [<xref rid="CIT0110" ref-type="bibr">110</xref>]), or de novo defined sets (Dendrix [<xref rid="CIT0109" ref-type="bibr">109</xref>], Muti-Dendrix [<xref rid="CIT0111" ref-type="bibr">111</xref>] or RME [<xref rid="CIT0112" ref-type="bibr">112</xref>]), enabling the discovery of novel combinations of mutated genes in cancer.</p></sec><sec id="S0008"><title>Identification of gene fusions</title><p>Gene fusions appear as a result of chromosomal rearrangements, such as deletion, insertion, inversion, or translocation. A fused gene is expressed as a hybrid entity encoding sequences of two distinct genes. Tumorigenic fusions successfully evade the gene regulation that its constituents are subjected to. Multiple cancer-related gene fusions have been identified, including prototypic BCR-ABL [<xref rid="CIT0113" ref-type="bibr">113</xref>], EML4-ALK [<xref rid="CIT0114" ref-type="bibr">114</xref>], TMPRSS2-ERG [<xref rid="CIT0115" ref-type="bibr">115</xref>], KIF5B-RET [<xref rid="CIT0116" ref-type="bibr">116</xref>], and others [<xref rid="CIT0007" ref-type="bibr">7</xref>, <xref rid="CIT0013" ref-type="bibr">13</xref>, <xref rid="CIT0014" ref-type="bibr">14</xref>, <xref rid="CIT0117" ref-type="bibr">117</xref>]. Such alterations may serve as a good cancer biomarker or therapeutic target [<xref rid="CIT0120" ref-type="bibr">120</xref>, <xref rid="CIT0121" ref-type="bibr">121</xref>]. Whole genome [<xref rid="CIT0075" ref-type="bibr">75</xref>, <xref rid="CIT0119" ref-type="bibr">119</xref>] and transcriptome sequencing [<xref rid="CIT0120" ref-type="bibr">120</xref>, <xref rid="CIT0121" ref-type="bibr">121</xref>] profiles can be used to identify fusions.</p><p>Transcriptome sequencing is proven to be superior over WGS and therefore is more commonly used. This is due to the fact that RNA-seq covers only transcribed sequences, which constitute a small percentage of the genome, thus reducing the cost, time, and resources needed for full analysis. Furthermore, RNA-seq provides information on the transcriptionally active fusion genes and their splicing variants. However, it also harbours certain limitations, including lack of information regarding non-transcribed regions and dependence on the heterogeneity in the expression levels between various cell types [<xref rid="CIT0122" ref-type="bibr">122</xref>]. Over the last few years several software packages (<xref ref-type="table" rid="T0006">Table 6</xref>) have been developed for the detection of gene fusions and/or structural variants (SV) that cause gene fusions. The majority of the software utilises RNA-seq data as an input. However, other tools use WGS data or both to increase the likelihood of detection of true fusion.
</p><table-wrap id="T0006" position="float"><label>Table 6</label><caption><p>Identifying gene fusions</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Method name</th><th valign="top" align="center" rowspan="1" colspan="1">Year published</th><th valign="top" align="center" rowspan="1" colspan="1">PMID</th><th valign="top" align="center" rowspan="1" colspan="1">Data type</th><th valign="top" align="center" rowspan="1" colspan="1">Platform</th><th valign="top" align="center" rowspan="1" colspan="1">Statistical method</th><th valign="top" align="center" rowspan="1" colspan="1">Input requirements</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BreakFusion</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22563071</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">C++, Perl</td><td align="left" rowspan="1" colspan="1">A computational pipeline for identifying gene fusions from RNA-seq data</td><td align="center" rowspan="1" colspan="1">BAM</td></tr><tr><td align="left" rowspan="1" colspan="1">BreakTrans</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23972288</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">Perl</td><td align="left" rowspan="1" colspan="1">Uncovering the genomic architecture of gene fusions</td><td align="center" rowspan="1" colspan="1">Tab-delimited text files</td></tr><tr><td align="left" rowspan="1" colspan="1">chimerascan</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">21840877</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">Python</td><td align="left" rowspan="1" colspan="1">Identifying chimeric transcription in sequencing data</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">comrad</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">21478487</td><td align="center" rowspan="1" colspan="1">RNA-seq, DNA-seq</td><td align="center" rowspan="1" colspan="1">C++</td><td align="left" rowspan="1" colspan="1">Discovery of gene fusions using paired end RNA-Seq and WGSS.</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">deFuse</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">21625565</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">C++</td><td align="left" rowspan="1" colspan="1">Detecting gene fusions from paired-end RNA-seq</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">FusionAnalyser</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22570408</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">C#</td><td align="left" rowspan="1" colspan="1">Detecting gene fusions from paired-end RNA-Seq data</td><td align="center" rowspan="1" colspan="1">SAM/BAM</td></tr><tr><td align="left" rowspan="1" colspan="1">FusionHunter</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">21546395</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">Perl</td><td align="left" rowspan="1" colspan="1">Detecting gene fusions from paired-end RNA-Seq data</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">FusionMap</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">21593131</td><td align="center" rowspan="1" colspan="1">RNA-seq, DNA-seq</td><td align="center" rowspan="1" colspan="1">C#</td><td align="left" rowspan="1" colspan="1">Detecting gene fusions from single- and paired-end RNA-Seq and DNA-seq data</td><td align="center" rowspan="1" colspan="1">FASTQ/BAM with unmapped reads</td></tr><tr><td align="left" rowspan="1" colspan="1">FusionSeq</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">20964841</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">A modular framework for finding gene fusions by analysing Paired-End RNA-Sequencing data</td><td align="center" rowspan="1" colspan="1">MRF, SAM</td></tr><tr><td align="left" rowspan="1" colspan="1">ShortFuse</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">21330288</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">C++, Python</td><td align="left" rowspan="1" colspan="1">Detecting gene fusions from paired-end RNA-Seq data</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="center" rowspan="1" colspan="1">SnowShoes-FTD</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">21622959</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">Perl</td><td align="left" rowspan="1" colspan="1">Detecting gene fusions from paired-end RNA-Seq data</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">SOAPfusion</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">24123671</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">Perl</td><td align="left" rowspan="1" colspan="1">Detecting gene fusions from paired-end RNA-Seq data</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr><tr><td align="left" rowspan="1" colspan="1">TopHat-Fusion</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">21835007</td><td align="center" rowspan="1" colspan="1">RNA-seq</td><td align="center" rowspan="1" colspan="1">C++</td><td align="left" rowspan="1" colspan="1">Detecting gene fusions from single- and paired-end RNA-Seq data</td><td align="center" rowspan="1" colspan="1">FASTQ</td></tr></tbody></table></table-wrap><p>The most common analysis steps for identifying gene fusions are as follows: (i) alignment and filtering, (ii) detection of fusion junctions in candidate genes, and (iii) fragment assembly and selection of putative fusions [<xref rid="CIT0122" ref-type="bibr">122</xref>]. Apart from mapping to the current reference genome available, RNA-seq reads are additionally mapped to annotated transcriptome libraries (e.g. RefSeq). The most commonly used mapping tool is Bowtie, due to its speed and high efficiency. The reads that map appropriately to the reference genome are filtered out from further analysis. The unmapped or discordantly mapped reads are fusion candidates that might be further passed through additional filters (e.g. ribosomal filter, repetitive region filter, short distance filter, etc.) to eliminate potential false negatives. Next, the reads remaining after filtration are divided into smaller fragments (so-called &#x0201c;split reads&#x0201d;) with even or pre-defined length, and both terminal parts are independently aligned to the reference genome. If they map to two different genes, they are further subjected to detection of fusion junction. The sequences of both genes are put together according to the fusion boundary, and the whole read is re-aligned to the candidate fusion gene to call supporting reads essential for the final selection of fusion. Another approach for the detection of fusion intersection is grouping discordantly mapped reads (&#x0201c;spanning reads&#x0201d;) according to the same breakpoints. Detection of fusion junction from such groups fuels prediction of the putative fusion transcript. Subsequently, the reads are re-aligned to predicted sequences and the predictions with the highest mapping scores aid identification of candidate fusion genes. The final selection of the fusion genes depends on several parameters including the number of supporting reads, quality of the alignment, and sequencing coverage [<xref rid="CIT0122" ref-type="bibr">122</xref>, <xref rid="CIT0123" ref-type="bibr">123</xref>].</p></sec><sec id="S0009"><title>Estimating sample purity</title><p>Most genomics and expression-profiling studies including TCGA use a mixture of different clonal populations of tumour cells, which is often contaminated with stromal and immune cells. Indeed, many common tumours, such as pancreatic tumours, are intensively infiltrated by stroma [<xref rid="CIT0124" ref-type="bibr">124</xref>] making it difficult to obtain homogenous material for genomic studies. Furthermore, epithelial cells are also often found in tumour samples, as they are at the interior surface of blood vessels necessary for providing nutrients for cancer cells. Methods like laser capture micro-dissection are rarely used in RNA-studies requiring stable material [<xref rid="CIT0125" ref-type="bibr">125</xref>]. Estimating purity and clonality of a tumour sample containing a mixed population of cells requires accurate measurement of the proportion of tumour and stromal cell samples. Over the years several different methods (<xref ref-type="table" rid="T0007">Table 7</xref>) have been developed to deconvolute genomic and transcriptomic data obtained from mixed-cell populations. Software packages based on these methods provide powerful tools for estimation of tumour heterogeneity and purity and in consequence identification of likely early driver events during tumorigenesis [<xref rid="CIT0126" ref-type="bibr">126</xref>].
</p><table-wrap id="T0007" position="float"><label>Table 7</label><caption><p>Available software for purity estimation</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Method name</th><th valign="top" align="center" rowspan="1" colspan="1">Year published</th><th valign="top" align="center" rowspan="1" colspan="1">PMID</th><th valign="top" align="center" rowspan="1" colspan="1">Data type (technique)</th><th valign="top" align="center" rowspan="1" colspan="1">Platform</th><th valign="top" align="center" rowspan="1" colspan="1">Statistical method</th><th valign="top" align="left" rowspan="1" colspan="1">Input requirements</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Dsection</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">20631160</td><td align="center" rowspan="1" colspan="1">RNA (Microarray)</td><td align="center" rowspan="1" colspan="1">Web-based and MATLAB</td><td align="center" rowspan="1" colspan="1">Bayesian model</td><td align="left" rowspan="1" colspan="1">Expression and proportion data required</td></tr><tr><td align="left" rowspan="1" colspan="1">csSAM</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">20208531</td><td align="center" rowspan="1" colspan="1">RNA (Microarray)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">Linear regression-based model</td><td align="left" rowspan="1" colspan="1">Expression profile of mixed tissue samples</td></tr><tr><td align="left" rowspan="1" colspan="1">mixture_estimation.R</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">20202973</td><td align="center" rowspan="1" colspan="1">RNA (Microarray)</td><td align="center" rowspan="1" colspan="1">R based</td><td align="center" rowspan="1" colspan="1">Variation of electronic subtraction method</td><td align="left" rowspan="1" colspan="1">Expression profile of mixed tissue samples</td></tr><tr><td align="left" rowspan="1" colspan="1">ASCAT</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">20837533</td><td align="center" rowspan="1" colspan="1">DNA (Microarray)</td><td align="center" rowspan="1" colspan="1">R based</td><td align="center" rowspan="1" colspan="1">Analytical optimisation method</td><td align="left" rowspan="1" colspan="1">SNP array data with Log R and B-Allele frequency information</td></tr><tr><td align="left" rowspan="1" colspan="1">PERT</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">23284283</td><td align="center" rowspan="1" colspan="1">RNA (Microarray)</td><td align="center" rowspan="1" colspan="1">Octave</td><td align="center" rowspan="1" colspan="1">Perturbation model</td><td align="left" rowspan="1" colspan="1">Expression data from mixed cell type and expression profile of each homogeneous cell type</td></tr><tr><td align="left" rowspan="1" colspan="1">ABSOLUTE</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22544022</td><td align="center" rowspan="1" colspan="1">DNA (Microarray and HTS)</td><td align="center" rowspan="1" colspan="1">R based</td><td align="center" rowspan="1" colspan="1">Gaussian mixture model</td><td align="left" rowspan="1" colspan="1">Copy number data in segmentation file</td></tr><tr><td align="left" rowspan="1" colspan="1">JointSNVMixl, JointSNVMix2</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22285562</td><td align="center" rowspan="1" colspan="1">DNA (HTS)</td><td align="center" rowspan="1" colspan="1">Python</td><td align="center" rowspan="1" colspan="1">Probabilistic graphical model</td><td align="left" rowspan="1" colspan="1">Sequence data from tumour/normal pairs</td></tr><tr><td align="left" rowspan="1" colspan="1">CNAnorm</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">22039209</td><td align="center" rowspan="1" colspan="1">DNA (HTS)</td><td align="center" rowspan="1" colspan="1">R based</td><td align="center" rowspan="1" colspan="1">Analytical optimization method</td><td align="left" rowspan="1" colspan="1">Sequencing data of tumour and normal samples in bam format</td></tr><tr><td align="left" rowspan="1" colspan="1">DeconRNASeq</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23428642</td><td align="center" rowspan="1" colspan="1">RNA (Microarray and HTS)</td><td align="center" rowspan="1" colspan="1">R based</td><td align="center" rowspan="1" colspan="1">Globally optimised nonnegative decomposition algorithm</td><td align="left" rowspan="1" colspan="1">Expression data from multiple tissue, signature of individual tissue and proportion data required</td></tr><tr><td align="left" rowspan="1" colspan="1">TEMT</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23735186</td><td align="center" rowspan="1" colspan="1">RNA (HTS)</td><td align="center" rowspan="1" colspan="1">Python</td><td align="center" rowspan="1" colspan="1">Probabilistic model including position and sequence-specific biases</td><td align="left" rowspan="1" colspan="1">Required RNA-seq sequencing data from pure tissue and mixed tissue</td></tr><tr><td align="left" rowspan="1" colspan="1">ESTIMATE</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">24113773</td><td align="center" rowspan="1" colspan="1">RNA (HTS)</td><td align="center" rowspan="1" colspan="1">R based</td><td align="center" rowspan="1" colspan="1">Gene signature (ssGSEA) based model</td><td align="left" rowspan="1" colspan="1">Expression data in Gene Set Enrichment Analysis (GSEA) gct format</td></tr><tr><td align="left" rowspan="1" colspan="1">THetA</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23895164</td><td align="center" rowspan="1" colspan="1">DNA (HTS)</td><td align="center" rowspan="1" colspan="1">Python</td><td align="center" rowspan="1" colspan="1">Explicit probabilistic model</td><td align="left" rowspan="1" colspan="1">Copy number data in interval count file format</td></tr><tr><td align="left" rowspan="1" colspan="1">ExPANdS</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">24177718</td><td align="center" rowspan="1" colspan="1">DNA (HTS)</td><td align="center" rowspan="1" colspan="1">R based and MATLAB</td><td align="center" rowspan="1" colspan="1">Probability distributions model</td><td align="left" rowspan="1" colspan="1">Somatic mutations and copy number data required</td></tr><tr><td align="left" rowspan="1" colspan="1">Virmid</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23987214</td><td align="center" rowspan="1" colspan="1">DNA (HTS)</td><td align="center" rowspan="1" colspan="1">Java based</td><td align="center" rowspan="1" colspan="1">Probabilistic model and maximum likelihood estimator</td><td align="left" rowspan="1" colspan="1">Disease and normal sequencing data in bam format</td></tr><tr><td align="left" rowspan="1" colspan="1">MuTect</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23396013</td><td align="center" rowspan="1" colspan="1">DNA (HTS)</td><td align="center" rowspan="1" colspan="1">Java based</td><td align="center" rowspan="1" colspan="1">Bayesian model</td><td align="left" rowspan="1" colspan="1">Tumour and normal sequencing data</td></tr><tr><td align="left" rowspan="1" colspan="1">TrAp</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23892400</td><td align="center" rowspan="1" colspan="1">DNA (HTS)</td><td align="center" rowspan="1" colspan="1">Java based</td><td align="center" rowspan="1" colspan="1">Linear mixture model with evolutionary framework</td><td align="left" rowspan="1" colspan="1">Tumour karyotypes and somatic hypermutation datasets</td></tr><tr><td align="left" rowspan="1" colspan="1">Seo <italic>et al</italic>.</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">23650637</td><td align="center" rowspan="1" colspan="1">RNA (Microarray)</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">Linear mixture model</td><td align="left" rowspan="1" colspan="1">Disease-associated variants and expression of heterogeneous normal tissue</td></tr></tbody></table></table-wrap></sec><sec id="S0010"><title>Comparative and integrative analysis of tumour samples</title><p>One of the major achievements of the TCGA project is the generation of different types of data from the same sample for a large number of tumours. This data generation is followed by uniform data processing and correlation with clinical information by Firehose and other analysis pipelines at various genome data analysis centres. The availability of such paired data allows detection of functional impact on genomic lesions (e.g. mutations, copy numbers, and gene fusions) on gene/miRNA (using RNA-Seq) and protein expression (using RPPA arrays) and pathway levels while reducing errors due to individual patient variation. Another example is the utilisation of multiple data types to identify integrated subtypes for a given tumour type using the iCLUSTER method [<xref rid="CIT0013" ref-type="bibr">13</xref>, <xref rid="CIT0014" ref-type="bibr">14</xref>, <xref rid="CIT0127" ref-type="bibr">127</xref>]. Other approaches include integration of pathway information (e.g. PARADIGM &#x00026; Paradigm-shift) and regulatory network information (e.g. GEMINI &#x02013; [<xref rid="CIT0128" ref-type="bibr">128</xref>]).</p><p>Comparative analysis of multiple tumour types increases the statistical power to detect common events that drive tumorigenesis and repurpose the therapy. For example, <italic>ERBB2-HER2</italic> is mutated and/or amplified in subsets of glioblastoma, gastric, serous endometrial, bladder, and lung cancers. The result, at least in some cases, is responsiveness to HER2-targeted therapy, analogous to that previously observed for <italic>HER2</italic>-amplified breast cancer. There are more examples that underscore the importance of such comparative analysis [<xref rid="CIT0004" ref-type="bibr">4</xref>].</p></sec><sec id="S0011"><title>Future of cancer profile analysis</title><p>As we are entering the era of $1000 genome sequencing, tumour profiles are being sequenced routinely. Moreover, tumour catalogues and pre-clinical models [<xref rid="CIT0129" ref-type="bibr">129</xref>, <xref rid="CIT0130" ref-type="bibr">130</xref>] have similar types of information available, with or without drug treatments. Integration of such datasets can speed up pre-clinical drug development and repurposing of available drugs. Tumour profiling by sequencing is also expected to enter both the pre-clinical and clinical setting for standardised testing as well as personalisation of medicine. However, the sequencing data fits the definition of &#x0201c;big data&#x0201d;, and a reliable computational infrastructure for storage, processing, analysis, and visualisation [<xref rid="CIT0131" ref-type="bibr">131</xref>, <xref rid="CIT0132" ref-type="bibr">132</xref>] is required to make most of this avalanche of information [<xref rid="CIT0133" ref-type="bibr">133</xref>]. Indeed, ambitious efforts like the cancer moonshot program and APOLLO launched by the UT MD Anderson Cancer Centre, aim to combine big data warehousing with IBM WATSON based cognitive and adaptive learning to reduce cancer mortality for several tumour types, will fully realise the power of tumour profiling.</p></sec></body><back><sec><title/><p>Authors declare no conflict of interest.</p><p>The authors thank Hubert &#x0015a;wierczy&#x00144;ski, Wojciech Pieklik, Juliusz Pukacki, and Dr Cezary Mazurek from the Poznan Supercomputing and Networking Centre affiliated to the Institute of Bioorganic Chemistry of the Polish Academy of Sciences for their help in preparation of the tables. This work was supported by the Foundation for Polish Science Welcome program grant No: 2010-3/3 to Maciej Wiznerowicz and UT MD Anderson Cancer Center intramural grants.</p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerlinger</surname><given-names>M</given-names></name><name><surname>Rowan</surname><given-names>AJ</given-names></name><name><surname>Horswell</surname><given-names>S</given-names></name><etal/></person-group><article-title>Intratumor heterogeneity and branched evolution revealed by multiregion sequencing</article-title><source>N Engl J Med</source><year>2012</year><volume>366</volume><fpage>883</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">22397650</pub-id></element-citation></ref><ref id="CIT0002"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju</surname><given-names>YS</given-names></name><name><surname>Alexandrov</surname><given-names>LB</given-names></name><name><surname>Gerstung</surname><given-names>M</given-names></name><etal/></person-group><article-title>Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer</article-title><source>Elife</source><year>2014</year><fpage>3</fpage></element-citation></ref><ref id="CIT0003"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>MS</given-names></name><name><surname>Stojanov</surname><given-names>P</given-names></name><name><surname>Polak</surname><given-names>P</given-names></name><etal/></person-group><article-title>Mutational heterogeneity in cancer and the search for new cancer-associated genes</article-title><source>Nature</source><year>2013</year><volume>499</volume><fpage>214</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23770567</pub-id></element-citation></ref><ref id="CIT0004"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname><given-names>JN</given-names></name><name><surname>Collisson</surname><given-names>EA</given-names></name><name><surname>Mills</surname><given-names>GB</given-names></name><etal/></person-group><article-title>The Cancer Genome Atlas Pan-Cancer analysis project</article-title><source>Nat Genet</source><year>2013</year><volume>45</volume><fpage>1113</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">24071849</pub-id></element-citation></ref><ref id="CIT0005"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stratton</surname><given-names>MR</given-names></name></person-group><article-title>Exploring the genomes of cancer cells: progress and promise</article-title><source>Science</source><year>2011</year><volume>331</volume><fpage>1553</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">21436442</pub-id></element-citation></ref><ref id="CIT0006"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Network</surname><given-names>TCGA</given-names></name></person-group><article-title>Comprehensive genomic characterization defines human glioblastoma genes and core pathways</article-title><source>Nature</source><year>2008</year><volume>455</volume><fpage>1061</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18772890</pub-id></element-citation></ref><ref id="CIT0007"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Network</surname><given-names>TCGA</given-names></name></person-group><article-title>Comprehensive genomic characterization of squamous cell lung cancers</article-title><source>Nature</source><year>2012</year><volume>489</volume><fpage>519</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">22960745</pub-id></element-citation></ref><ref id="CIT0008"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Network</surname><given-names>TCGA</given-names></name></person-group><article-title>Comprehensive molecular portraits of human breast tumours</article-title><source>Nature</source><year>2012</year><volume>490</volume><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">23000897</pub-id></element-citation></ref><ref id="CIT0009"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>SE</given-names></name><name><surname>Chester</surname><given-names>JD</given-names></name></person-group><article-title>Personalised cancer medicine</article-title><source>Int J Cancer</source><year>2014</year><comment>[Epub]</comment></element-citation></ref><ref id="CIT0010"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanneman</surname><given-names>M</given-names></name><name><surname>Dranoff</surname><given-names>G</given-names></name></person-group><article-title>Combining immunotherapy and targeted therapies in cancer treatment</article-title><source>Nat Rev Cancer</source><year>2012</year><volume>12</volume><fpage>237</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">22437869</pub-id></element-citation></ref><ref id="CIT0011"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capdeville</surname><given-names>R</given-names></name><name><surname>Buchdunger</surname><given-names>E</given-names></name><name><surname>Zimmermann</surname><given-names>J</given-names></name><name><surname>Matter</surname><given-names>A</given-names></name></person-group><article-title>Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug</article-title><source>Nat Rev Drug Discov</source><year>2002</year><volume>1</volume><fpage>493</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">12120256</pub-id></element-citation></ref><ref id="CIT0012"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagayama</surname><given-names>A</given-names></name><name><surname>Hayashida</surname><given-names>T</given-names></name><name><surname>Jinno</surname><given-names>H</given-names></name><etal/></person-group><article-title>Comparative effectiveness of neoadjuvant therapy for HER2-positive breast cancer: a network meta-analysis</article-title><source>J Natl Cancer Inst</source><year>2014</year><fpage>106</fpage></element-citation></ref><ref id="CIT0013"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Network</surname><given-names>TCGA</given-names></name></person-group><article-title>Comprehensive molecular characterization of gastric adenocarcinoma</article-title><source>Nature</source><year>2014</year><volume>513</volume><fpage>202</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">25079317</pub-id></element-citation></ref><ref id="CIT0014"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Network</surname><given-names>TCGA</given-names></name></person-group><article-title>Comprehensive molecular profiling of lung adenocarcinoma</article-title><source>Nature</source><year>2014</year><volume>511</volume><fpage>543</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">25079552</pub-id></element-citation></ref><ref id="CIT0015"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Network</surname><given-names>TCGA</given-names></name></person-group><article-title>Comprehensive molecular characterization of human colon and rectal cancer</article-title><source>Nature</source><year>2012</year><volume>487</volume><fpage>330</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22810696</pub-id></element-citation></ref><ref id="CIT0016"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>GM</given-names></name><name><surname>Fortney</surname><given-names>A</given-names></name><name><surname>Gorreta</surname><given-names>F</given-names></name><etal/></person-group><article-title>Microarrays in cancer research</article-title><source>Anticancer Res</source><year>2004</year><volume>24</volume><fpage>441</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15152942</pub-id></element-citation></ref><ref id="CIT0017"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metzker</surname><given-names>ML</given-names></name></person-group><article-title>Sequencing technologies &#x02013; the next generation</article-title><source>Nat Rev Genet</source><year>2010</year><volume>11</volume><fpage>31</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">19997069</pub-id></element-citation></ref><ref id="CIT0018"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Fung-Leung</surname><given-names>WP</given-names></name><name><surname>Bittner</surname><given-names>A</given-names></name><name><surname>Ngo</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group><article-title>Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e78644</fpage><pub-id pub-id-type="pmid">24454679</pub-id></element-citation></ref><ref id="CIT0019"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irizarry</surname><given-names>RA</given-names></name><name><surname>Warren</surname><given-names>D</given-names></name><name><surname>Spencer</surname><given-names>F</given-names></name><etal/></person-group><article-title>Multiple-laboratory comparison of microarray platforms</article-title><source>Nat Methods</source><year>2005</year><volume>2</volume><fpage>345</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">15846361</pub-id></element-citation></ref><ref id="CIT0020"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>MK</given-names></name><name><surname>Churchill</surname><given-names>GA</given-names></name></person-group><article-title>Experimental design for gene expression microarrays</article-title><source>Biostatistics</source><year>2001</year><volume>2</volume><fpage>183</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">12933549</pub-id></element-citation></ref><ref id="CIT0021"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quackenbush</surname><given-names>J</given-names></name></person-group><article-title>Microarray data normalization and transformation</article-title><source>Nat Genet</source><year>2002</year><volume>32</volume><issue>Suppl</issue><fpage>496</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">12454644</pub-id></element-citation></ref><ref id="CIT0022"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>YH</given-names></name><name><surname>Speed</surname><given-names>T</given-names></name></person-group><article-title>Design issues for cDNA microarray experiments</article-title><source>Nat Rev Genet</source><year>2002</year><volume>3</volume><fpage>579</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">12154381</pub-id></element-citation></ref><ref id="CIT0023"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkodsi</surname><given-names>A</given-names></name><name><surname>Louhimo</surname><given-names>R</given-names></name><name><surname>Hautaniemi</surname><given-names>S</given-names></name></person-group><article-title>Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data</article-title><source>Brief Bioinform</source><year>2014</year><comment>(Epub)</comment></element-citation></ref><ref id="CIT0024"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name></person-group><article-title>Sense from sequence reads: methods for alignment and assembly</article-title><source>Nat Meth</source><year>2009</year><volume>6</volume><fpage>S6</fpage><lpage>12</lpage></element-citation></ref><ref id="CIT0025"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medvedev</surname><given-names>P</given-names></name><name><surname>Stanciu</surname><given-names>M</given-names></name><name><surname>Brudno</surname><given-names>M</given-names></name></person-group><article-title>Computational methods for discovering structural variation with next-generation sequencing</article-title><source>Nat Meth</source><year>2009</year><volume>6</volume><fpage>S13</fpage><lpage>20</lpage></element-citation></ref><ref id="CIT0026"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>R</given-names></name><name><surname>Paul</surname><given-names>JS</given-names></name><name><surname>Albrechtsen</surname><given-names>A</given-names></name><name><surname>Song</surname><given-names>YS</given-names></name></person-group><article-title>Genotype and SNP calling from next-generation sequencing data</article-title><source>Nat Rev Genet</source><year>2011</year><volume>12</volume><fpage>443</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">21587300</pub-id></element-citation></ref><ref id="CIT0027"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepke</surname><given-names>S</given-names></name><name><surname>Wold</surname><given-names>B</given-names></name><name><surname>Mortazavi</surname><given-names>A</given-names></name></person-group><article-title>Computation for ChIP-seq and RNA-seq studies</article-title><source>Nat Meth</source><year>2009</year><volume>6</volume><fpage>S22</fpage><lpage>32</lpage></element-citation></ref><ref id="CIT0028"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soneson</surname><given-names>C</given-names></name><name><surname>Delorenzi</surname><given-names>M</given-names></name></person-group><article-title>A comparison of methods for differential expression analysis of RNA-seq data</article-title><source>BMC Bioinformatics</source><year>2013</year><volume>14</volume><fpage>91</fpage><pub-id pub-id-type="pmid">23497356</pub-id></element-citation></ref><ref id="CIT0029"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Fabbro</surname><given-names>C</given-names></name><name><surname>Scalabrin</surname><given-names>S</given-names></name><name><surname>Morgante</surname><given-names>M</given-names></name><name><surname>Giorgi</surname><given-names>FM</given-names></name></person-group><article-title>An extensive evaluation of read trimming effects on illumina NGS data analysis</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e85024</fpage><pub-id pub-id-type="pmid">24376861</pub-id></element-citation></ref><ref id="CIT0030"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Vongsangnak</surname><given-names>W</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name></person-group><article-title>Evaluation and comparison of multiple aligners for next-generation sequencing data analysis</article-title><source>Biomed Res Int</source><year>2014</year><volume>2014</volume><fpage>309650</fpage><pub-id pub-id-type="pmid">24779008</pub-id></element-citation></ref><ref id="CIT0031"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soneson</surname><given-names>C</given-names></name><name><surname>Delorenzi</surname><given-names>M</given-names></name></person-group><article-title>A comparison of methods for differential expression analysis of RNA-seq data</article-title><source>BMC Bioinformatics</source><year>2013</year><volume>14</volume><fpage>91</fpage><pub-id pub-id-type="pmid">23497356</pub-id></element-citation></ref><ref id="CIT0032"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horner</surname><given-names>DS</given-names></name><name><surname>Pavesi</surname><given-names>G</given-names></name><name><surname>Castrignan&#x000f2;</surname><given-names>T</given-names></name><name><surname>De Meo</surname><given-names>PD</given-names></name><name><surname>Liuni</surname><given-names>S</given-names></name><name><surname>Sammeth</surname><given-names>M</given-names></name><name><surname>Picardi</surname><given-names>E</given-names></name><name><surname>Pesole</surname><given-names>G</given-names></name></person-group><article-title>Bioinformatics approaches for genomics and post genomics applications of next-generation sequencing</article-title><source>Brief Bioinform</source><year>2010</year><volume>11</volume><fpage>181</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">19864250</pub-id></element-citation></ref><ref id="CIT0033"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Khaleel</surname><given-names>SS</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>CH</given-names></name></person-group><article-title>Software for pre-processing Illumina next-generation sequencing short read sequences</article-title><source>Source Code Biol Med</source><year>2014</year><volume>9</volume><fpage>8</fpage><pub-id pub-id-type="pmid">24955109</pub-id></element-citation></ref><ref id="CIT0034"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>JR</given-names></name><name><surname>Koren</surname><given-names>S</given-names></name><name><surname>Sutton</surname><given-names>G</given-names></name></person-group><article-title>Assembly algorithms for next-generation sequencing data</article-title><source>Genomics</source><year>2010</year><volume>95</volume><fpage>315</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">20211242</pub-id></element-citation></ref><ref id="CIT0035"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Pop</surname><given-names>M</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</article-title><source>Genome Biol</source><year>2009</year><volume>10</volume><fpage>R25</fpage><pub-id pub-id-type="pmid">19261174</pub-id></element-citation></ref><ref id="CIT0036"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Pachter</surname><given-names>L</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><article-title>TopHat: discovering splice junctions with RNA-Seq</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><fpage>1105</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">19289445</pub-id></element-citation></ref><ref id="CIT0037"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>G-Z</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Ma</surname><given-names>Y-K</given-names></name><name><surname>Wang</surname><given-names>X-J</given-names></name></person-group><article-title>ISRNA: an integrative online toolkit for short reads from high-throughput sequencing data</article-title><source>Bioinformatics</source><year>2014</year><volume>30</volume><fpage>434</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">24300438</pub-id></element-citation></ref><ref id="CIT0038"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><article-title>Differential expression analysis for sequence count data</article-title><source>Genome Biol</source><year>2010</year><volume>11</volume><fpage>R106</fpage><pub-id pub-id-type="pmid">20979621</pub-id></element-citation></ref><ref id="CIT0039"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auer</surname><given-names>PLDR</given-names></name></person-group><article-title>A two-stage poisson model for testing RNA-seq data</article-title><source>Stat Appl Gen Mol Biol</source><year>2011</year><fpage>10</fpage><comment>Article 26.</comment></element-citation></ref><ref id="CIT0040"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di</surname><given-names>YSD</given-names></name><name><surname>Cumbie</surname><given-names>JS</given-names></name><name><surname>Chang</surname><given-names>JH</given-names></name></person-group><article-title>The NBP negative binomial model for assessing differential gene expression from RNA-seq</article-title><source>Stat Appl Genet Mol Biol</source><year>2011</year><volume>10</volume><comment>Article 24</comment></element-citation></ref><ref id="CIT0041"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardcastle</surname><given-names>TJ</given-names></name><name><surname>Kelly</surname><given-names>KA</given-names></name></person-group><article-title>baySeq: empirical Bayesian methods for identifying differential expression in sequence count data</article-title><source>BMC Bioinformatics</source><year>2010</year><volume>11</volume><fpage>422</fpage><pub-id pub-id-type="pmid">20698981</pub-id></element-citation></ref><ref id="CIT0042"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>Small-sample estimation of negative binomial dispersion, with applications to SAGE data</article-title><source>Biostatistics</source><year>2008</year><volume>9</volume><fpage>321</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">17728317</pub-id></element-citation></ref><ref id="CIT0043"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>YH</given-names></name><name><surname>Xia</surname><given-names>K</given-names></name><name><surname>Wright</surname><given-names>FA</given-names></name></person-group><article-title>A powerful and flexible approach to the analysis of RNA sequence count data</article-title><source>Bioinformatics</source><year>2011</year><volume>27</volume><fpage>2672</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21810900</pub-id></element-citation></ref><ref id="CIT0044"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bullard</surname><given-names>J</given-names></name><name><surname>Purdom</surname><given-names>E</given-names></name><name><surname>Hansen</surname><given-names>K</given-names></name><name><surname>Dudoit</surname><given-names>S</given-names></name></person-group><article-title>Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments</article-title><source>BMC Bioinformatics</source><year>2010</year><volume>11</volume><fpage>94</fpage><pub-id pub-id-type="pmid">20167110</pub-id></element-citation></ref><ref id="CIT0045"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marioni</surname><given-names>JC</given-names></name><name><surname>Mason</surname><given-names>CE</given-names></name><name><surname>Mane</surname><given-names>SM</given-names></name><name><surname>Stephens</surname><given-names>M</given-names></name><name><surname>Gilad</surname><given-names>Y</given-names></name></person-group><article-title>RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays</article-title><source>Genome Res</source><year>2008</year><volume>18</volume><fpage>1509</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">18550803</pub-id></element-citation></ref><ref id="CIT0046"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denoeud</surname><given-names>F</given-names></name><name><surname>Kapranov</surname><given-names>P</given-names></name><name><surname>Ucla</surname><given-names>C</given-names></name><etal/></person-group><article-title>Prominent use of distal 5&#x02019; transcription start sites and discovery of a large number of additional exons in ENCODE regions</article-title><source>Genome Res</source><year>2007</year><volume>17</volume><fpage>746</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">17567994</pub-id></element-citation></ref><ref id="CIT0047"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tress</surname><given-names>ML</given-names></name><name><surname>Martelli</surname><given-names>PL</given-names></name><name><surname>Frankish</surname><given-names>A</given-names></name><etal/></person-group><article-title>The implications of alternative splicing in the ENCODE protein complement</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>5495</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">17372197</pub-id></element-citation></ref><ref id="CIT0048"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Yeh</surname><given-names>I</given-names></name><name><surname>Park</surname><given-names>JY</given-names></name><name><surname>Tian</surname><given-names>B</given-names></name></person-group><article-title>PolyA_DB 2: mRNA polyadenylation sites in vertebrate genes</article-title><source>Nucleic Acids Res</source><year>2007</year><volume>35</volume><fpage>D165</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17202160</pub-id></element-citation></ref><ref id="CIT0049"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>BC-M</given-names></name><etal/></person-group><article-title>Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome</article-title><source>Nat Biotech</source><year>2012</year><volume>30</volume><fpage>253</fpage><lpage>60</lpage></element-citation></ref><ref id="CIT0050"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramaswami</surname><given-names>G</given-names></name><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Piskol</surname><given-names>R</given-names></name><name><surname>Tan</surname><given-names>MH</given-names></name><name><surname>Davis</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>JB</given-names></name></person-group><article-title>Accurate identification of human Alu and non-Alu RNA editing sites</article-title><source>Nat Meth</source><year>2012</year><volume>9</volume><fpage>579</fpage><lpage>81</lpage></element-citation></ref><ref id="CIT0051"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramaswami</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Piskol</surname><given-names>R</given-names></name><name><surname>Keegan</surname><given-names>LP</given-names></name><name><surname>Deng</surname><given-names>P</given-names></name><name><surname>O'Connell</surname><given-names>MA</given-names></name><name><surname>Li</surname><given-names>JB</given-names></name></person-group><article-title>Identifying RNA editing sites using RNA sequencing data alone</article-title><source>Nat Meth</source><year>2013</year><volume>10</volume><fpage>128</fpage><lpage>32</lpage></element-citation></ref><ref id="CIT0052"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregg</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Weissbourd</surname><given-names>B</given-names></name><name><surname>Luo</surname><given-names>S</given-names></name><name><surname>Schroth</surname><given-names>GP</given-names></name><name><surname>Haig</surname><given-names>D</given-names></name><name><surname>Dulac</surname><given-names>C</given-names></name></person-group><article-title>High-resolution analysis of parent-of-origin allelic expression in the mouse brain</article-title><source>Science</source><year>2010</year><volume>329</volume><fpage>643</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20616232</pub-id></element-citation></ref><ref id="CIT0053"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Ramaswami</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>KS</given-names></name><name><surname>Turecki</surname><given-names>G</given-names></name><name><surname>Montgomery</surname><given-names>SB</given-names></name><name><surname>Li</surname><given-names>JB</given-names></name></person-group><article-title>Quantifying RNA allelic ratios by microfluidic multiplex PCR and sequencing</article-title><source>Nat Methods</source><year>2014</year><volume>11</volume><fpage>51</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">24270603</pub-id></element-citation></ref><ref id="CIT0054"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabili</surname><given-names>MN</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Goff</surname><given-names>L</given-names></name><name><surname>Koziol</surname><given-names>M</given-names></name><name><surname>Tazon-Vega</surname><given-names>B</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Rinn</surname><given-names>JL</given-names></name></person-group><article-title>Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses</article-title><source>Genes Dev</source><year>2011</year><volume>25</volume><fpage>1915</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">21890647</pub-id></element-citation></ref><ref id="CIT0055"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djebali</surname><given-names>S</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Merkel</surname><given-names>A</given-names></name><etal/></person-group><article-title>Landscape of transcription in human cells</article-title><source>Nature</source><year>2012</year><volume>489</volume><fpage>101</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">22955620</pub-id></element-citation></ref><ref id="CIT0056"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoury</surname><given-names>JD</given-names></name><name><surname>Tannir</surname><given-names>NM</given-names></name><name><surname>Williams</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq</article-title><source>J Virol</source><year>2013</year><volume>87</volume><fpage>8916</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">23740984</pub-id></element-citation></ref><ref id="CIT0057"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>K-W</given-names></name><name><surname>Alaei-Mahabadi</surname><given-names>B</given-names></name><name><surname>Samuelsson</surname><given-names>T</given-names></name><name><surname>Lindh</surname><given-names>M</given-names></name><name><surname>Larsson</surname><given-names>E</given-names></name></person-group><article-title>The landscape of viral expression and host gene fusion and adaptation in human cancer</article-title><source>Nat Commun</source><year>2013</year><volume>4</volume><fpage>2513</fpage><pub-id pub-id-type="pmid">24085110</pub-id></element-citation></ref><ref id="CIT0058"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piskol</surname><given-names>R</given-names></name><name><surname>Ramaswami</surname><given-names>G</given-names></name><name><surname>Li Jin</surname><given-names>B</given-names></name></person-group><article-title>Reliable identification of genomic variants from RNA-Seq dData</article-title><source>Am J Hum Genet.</source><year>2013</year><volume>93</volume><fpage>641</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">24075185</pub-id></element-citation></ref><ref id="CIT0059"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Futreal</surname><given-names>PA</given-names></name><name><surname>Coin</surname><given-names>L</given-names></name><name><surname>Marshall</surname><given-names>M</given-names></name><name><surname>Down</surname><given-names>T</given-names></name><name><surname>Hubbard</surname><given-names>T</given-names></name><name><surname>Wooster</surname><given-names>R</given-names></name><name><surname>Rahman</surname><given-names>N</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name></person-group><article-title>A census of human cancer genes</article-title><source>Nat Rev Cancer</source><year>2004</year><volume>4</volume><fpage>177</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">14993899</pub-id></element-citation></ref><ref id="CIT0060"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TM</given-names></name><name><surname>Xi</surname><given-names>R</given-names></name><name><surname>Luquette</surname><given-names>LJ</given-names></name><name><surname>Park</surname><given-names>RW</given-names></name><name><surname>Johnson</surname><given-names>MD</given-names></name><name><surname>Park</surname><given-names>PJ</given-names></name></person-group><article-title>Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomes</article-title><source>Genome Res</source><year>2013</year><volume>23</volume><fpage>217</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">23132910</pub-id></element-citation></ref><ref id="CIT0061"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Negrini</surname><given-names>S</given-names></name><name><surname>Gorgoulis</surname><given-names>VG</given-names></name><name><surname>Halazonetis</surname><given-names>TD</given-names></name></person-group><article-title>Genomic instability &#x02013; an evolving hallmark of cancer</article-title><source>Nat Rev Mol Cell Biol</source><year>2010</year><volume>11</volume><fpage>220</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20177397</pub-id></element-citation></ref><ref id="CIT0062"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baudis</surname><given-names>M</given-names></name></person-group><article-title>Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data</article-title><source>BMC Cancer</source><year>2007</year><volume>7</volume><fpage>226</fpage><pub-id pub-id-type="pmid">18088415</pub-id></element-citation></ref><ref id="CIT0063"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>M</given-names></name></person-group><article-title>Molecular pathogenesis and mechanisms of thyroid cancer</article-title><source>Nat Rev Cancer</source><year>2013</year><volume>13</volume><fpage>184</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">23429735</pub-id></element-citation></ref><ref id="CIT0064"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000f6;hner</surname><given-names>H</given-names></name><name><surname>Stilgenbauer</surname><given-names>S</given-names></name><name><surname>Benner</surname><given-names>A</given-names></name><etal/></person-group><article-title>Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia</article-title><source>N Engl J Med</source><year>2000</year><volume>343</volume><fpage>1910</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11136261</pub-id></element-citation></ref><ref id="CIT0065"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louhimo</surname><given-names>R</given-names></name><name><surname>Lepikhova</surname><given-names>T</given-names></name><name><surname>Monni</surname><given-names>O</given-names></name><name><surname>Hautaniemi</surname><given-names>S</given-names></name></person-group><article-title>Comparative analysis of algorithms for integration of copy number and expression data</article-title><source>Nat Meth</source><year>2012</year><volume>9</volume><fpage>351</fpage><lpage>5</lpage></element-citation></ref><ref id="CIT0066"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallioniemi</surname><given-names>A</given-names></name><name><surname>Kallioniemi</surname><given-names>O</given-names></name><name><surname>Sudar</surname><given-names>D</given-names></name><name><surname>Rutovitz</surname><given-names>D</given-names></name><name><surname>Gray</surname><given-names>JW</given-names></name><name><surname>Waldman</surname><given-names>F</given-names></name><name><surname>Pinkel</surname><given-names>D</given-names></name></person-group><article-title>Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors</article-title><source>Science</source><year>1992</year><volume>258</volume><fpage>818</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">1359641</pub-id></element-citation></ref><ref id="CIT0067"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullighan</surname><given-names>CG</given-names></name><name><surname>Downing</surname><given-names>JR</given-names></name></person-group><article-title>Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions</article-title><source>Leukemia</source><year>2009</year><volume>23</volume><fpage>1209</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">19242497</pub-id></element-citation></ref><ref id="CIT0068"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weir</surname><given-names>BA</given-names></name><name><surname>Woo</surname><given-names>MS</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><etal/></person-group><article-title>Characterizing the cancer genome in lung adenocarcinoma</article-title><source>Nature</source><year>2007</year><volume>450</volume><fpage>893</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17982442</pub-id></element-citation></ref><ref id="CIT0069"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>DY</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Jaffe</surname><given-names>DB</given-names></name><etal/></person-group><article-title>High-resolution mapping of copy-number alterations with massively parallel sequencing</article-title><source>Nat Meth</source><year>2009</year><volume>6</volume><fpage>99</fpage><lpage>103</lpage></element-citation></ref><ref id="CIT0070"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinkel</surname><given-names>D</given-names></name><name><surname>Segraves</surname><given-names>R</given-names></name><name><surname>Sudar</surname><given-names>D</given-names></name><etal/></person-group><article-title>High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays</article-title><source>Nat Genet</source><year>1998</year><volume>20</volume><fpage>207</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">9771718</pub-id></element-citation></ref><ref id="CIT0071"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bignell</surname><given-names>GR</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Greshock</surname><given-names>J</given-names></name><etal/></person-group><article-title>High-resolution analysis of DNA copy number using oligonucleotide microarrays</article-title><source>Genome Res</source><year>2004</year><volume>14</volume><fpage>287</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">14762065</pub-id></element-citation></ref><ref id="CIT0072"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handsaker</surname><given-names>RE</given-names></name><name><surname>Korn</surname><given-names>JM</given-names></name><name><surname>Nemesh</surname><given-names>J</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name></person-group><article-title>Discovery and genotyping of genome structural polymorphism by sequencing on a population scale</article-title><source>Nat Genet</source><year>2011</year><volume>43</volume><fpage>269</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">21317889</pub-id></element-citation></ref><ref id="CIT0073"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>S</given-names></name><name><surname>Xuan</surname><given-names>Z</given-names></name><name><surname>Makarov</surname><given-names>V</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name><name><surname>Sebat</surname><given-names>J</given-names></name></person-group><article-title>Sensitive and accurate detection of copy number variants using read depth of coverage</article-title><source>Genome Res</source><year>2009</year><volume>19</volume><fpage>1586</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">19657104</pub-id></element-citation></ref><ref id="CIT0074"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuzun</surname><given-names>E</given-names></name><name><surname>Sharp</surname><given-names>AJ</given-names></name><name><surname>Bailey</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Fine-scale structural variation of the human genome</article-title><source>Nat Genet</source><year>2005</year><volume>37</volume><fpage>727</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">15895083</pub-id></element-citation></ref><ref id="CIT0075"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>PJ</given-names></name><name><surname>Stephens</surname><given-names>PJ</given-names></name><name><surname>Pleasance</surname><given-names>ED</given-names></name><etal/></person-group><article-title>Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing</article-title><source>Nat Genet</source><year>2008</year><volume>40</volume><fpage>722</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18438408</pub-id></element-citation></ref><ref id="CIT0076"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karakoc</surname><given-names>E</given-names></name><name><surname>Alkan</surname><given-names>C</given-names></name><name><surname>O'Roak</surname><given-names>BJ</given-names></name><name><surname>Dennis</surname><given-names>MY</given-names></name><name><surname>Vives</surname><given-names>L</given-names></name><name><surname>Mark</surname><given-names>K</given-names></name><name><surname>Rieder</surname><given-names>MJ</given-names></name><name><surname>Nickerson</surname><given-names>DA</given-names></name><name><surname>Eichler</surname><given-names>EE</given-names></name></person-group><article-title>Detection of structural variants and indels within exome data</article-title><source>Nat Meth</source><year>2012</year><volume>9</volume><fpage>176</fpage><lpage>8</lpage></element-citation></ref><ref id="CIT0077"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fromer</surname><given-names>M</given-names></name><name><surname>Moran</surname><given-names>JL</given-names></name><name><surname>Chambert</surname><given-names>K</given-names></name><etal/></person-group><article-title>Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth</article-title><source>Am J Hum Genet</source><year>2012</year><volume>91</volume><fpage>597</fpage><lpage>607</lpage><pub-id pub-id-type="pmid">23040492</pub-id></element-citation></ref><ref id="CIT0078"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soon</surname><given-names>WW</given-names></name><name><surname>Hariharan</surname><given-names>M</given-names></name><name><surname>Snyder</surname><given-names>MP</given-names></name></person-group><article-title>High-throughput sequencing for biology and medicine</article-title><source>Mol Syst Biol</source><year>2013</year><volume>9</volume><fpage>640</fpage><pub-id pub-id-type="pmid">23340846</pub-id></element-citation></ref><ref id="CIT0079"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Papadopoulos</surname><given-names>N</given-names></name><name><surname>Velculescu</surname><given-names>VE</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Diaz</surname><given-names>LA</given-names><suffix>Jr</suffix></name><name><surname>Kinzler</surname><given-names>KW</given-names></name></person-group><article-title>Cancer genome landscapes</article-title><source>Science</source><year>2013</year><volume>339</volume><fpage>1546</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">23539594</pub-id></element-citation></ref><ref id="CIT0080"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Jia</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Ji</surname><given-names>H</given-names></name><name><surname>Hucks</surname><given-names>D</given-names></name><name><surname>Dahlman</surname><given-names>KB</given-names></name><name><surname>Pao</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name></person-group><article-title>Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers</article-title><source>Genome Med</source><year>2013</year><volume>5</volume><fpage>91</fpage><pub-id pub-id-type="pmid">24112718</pub-id></element-citation></ref><ref id="CIT0081"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christoforides</surname><given-names>A</given-names></name><name><surname>Carpten</surname><given-names>JD</given-names></name><name><surname>Weiss</surname><given-names>GJ</given-names></name><name><surname>Demeure</surname><given-names>MJ</given-names></name><name><surname>Von Hoff</surname><given-names>DD</given-names></name><name><surname>Craig</surname><given-names>DW</given-names></name></person-group><article-title>Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs</article-title><source>BMC Genomics</source><year>2013</year><volume>14</volume><fpage>302</fpage><pub-id pub-id-type="pmid">23642077</pub-id></element-citation></ref><ref id="CIT0082"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowell</surname><given-names>PC</given-names></name></person-group><article-title>The clonal evolution of tumor cell populations</article-title><source>Science</source><year>1976</year><volume>194</volume><fpage>23</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">959840</pub-id></element-citation></ref><ref id="CIT0083"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cibulskis</surname><given-names>K</given-names></name><name><surname>Lawrence</surname><given-names>MS</given-names></name><name><surname>Carter</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples</article-title><source>Nat Biotechnol</source><year>2013</year><volume>31</volume><fpage>213</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">23396013</pub-id></element-citation></ref><ref id="CIT0084"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>CT</given-names></name><name><surname>Wong</surname><given-names>WS</given-names></name><name><surname>Swamy</surname><given-names>S</given-names></name><name><surname>Becq</surname><given-names>J</given-names></name><name><surname>Murray</surname><given-names>LJ</given-names></name><name><surname>Cheetham</surname><given-names>RK</given-names></name></person-group><article-title>Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs</article-title><source>Bioinformatics</source><year>2012</year><volume>28</volume><fpage>1811</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22581179</pub-id></element-citation></ref><ref id="CIT0085"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koboldt</surname><given-names>DC</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Larson</surname><given-names>DE</given-names></name><etal/></person-group><article-title>VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing</article-title><source>Genome Res</source><year>2012</year><volume>22</volume><fpage>568</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">22300766</pub-id></element-citation></ref><ref id="CIT0086"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname><given-names>RLJ</given-names></name><name><surname>Hadjipanayis</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>TM</given-names></name><name><surname>Park</surname><given-names>PJ</given-names></name></person-group><article-title>BIC-seq: a fast algorithm for detection of copy number alterations based on high-throughput sequencing data</article-title><source>Genome Biol</source><year>2010</year><volume>11</volume><fpage>O10</fpage></element-citation></ref><ref id="CIT0087"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Luquette Lovelace</surname><given-names>J</given-names></name><name><surname>Gehlenborg</surname><given-names>N</given-names></name><etal/></person-group><article-title>Diverse mechanisms of somatic structural variations in human cancer genomes</article-title><source>Cell</source><volume>153</volume><fpage>919</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">23663786</pub-id></element-citation></ref><ref id="CIT0088"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krumm</surname><given-names>N</given-names></name><name><surname>Sudmant</surname><given-names>PH</given-names></name><name><surname>Ko</surname><given-names>A</given-names></name><etal/></person-group><article-title>Copy number variation detection and genotyping from exome sequence data</article-title><source>Genome Res</source><year>2012</year><volume>22</volume><fpage>1525</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">22585873</pub-id></element-citation></ref><ref id="CIT0089"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Wallis</surname><given-names>JW</given-names></name><name><surname>McLellan</surname><given-names>MD</given-names></name><etal/></person-group><article-title>BreakDancer: an algorithm for high-resolution mapping of genomic structural variation</article-title><source>Nat Methods</source><year>2009</year><volume>6</volume><fpage>677</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">19668202</pub-id></element-citation></ref><ref id="CIT0090"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marx</surname><given-names>V</given-names></name></person-group><article-title>Cancer genomes: discerning drivers from passengers</article-title><source>Nat Meth</source><year>2014</year><volume>11</volume><fpage>375</fpage><lpage>9</lpage></element-citation></ref><ref id="CIT0091"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merid</surname><given-names>SK</given-names></name><name><surname>Goranskaya</surname><given-names>D</given-names></name><name><surname>Alexeyenko</surname><given-names>A</given-names></name></person-group><article-title>Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis</article-title><source>BMC Bioinformatics</source><year>2014</year><volume>15</volume><fpage>308</fpage><pub-id pub-id-type="pmid">25236784</pub-id></element-citation></ref><ref id="CIT0092"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raphael</surname><given-names>BJ</given-names></name><name><surname>Dobson</surname><given-names>JR</given-names></name><name><surname>Oesper</surname><given-names>L</given-names></name><name><surname>Vandin</surname><given-names>F</given-names></name></person-group><article-title>Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine</article-title><source>Genome Med</source><year>2014</year><volume>6</volume><fpage>5</fpage><pub-id pub-id-type="pmid">24479672</pub-id></element-citation></ref><ref id="CIT0093"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dees</surname><given-names>ND</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Kandoth</surname><given-names>C</given-names></name><etal/></person-group><article-title>MuSiC: identifying mutational significance in cancer genomes</article-title><source>Genome Res</source><year>2012</year><volume>22</volume><fpage>1589</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">22759861</pub-id></element-citation></ref><ref id="CIT0094"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name></person-group><article-title>DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies</article-title><source>Am J Hum Genet</source><year>2013</year><volume>93</volume><fpage>439</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">23954162</pub-id></element-citation></ref><ref id="CIT0095"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mermel</surname><given-names>CH</given-names></name><name><surname>Schumacher</surname><given-names>SE</given-names></name><name><surname>Hill</surname><given-names>B</given-names></name><name><surname>Meyerson</surname><given-names>ML</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name></person-group><article-title>GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers</article-title><source>Genome Biol</source><year>2011</year><volume>12</volume><fpage>R41</fpage><pub-id pub-id-type="pmid">21527027</pub-id></element-citation></ref><ref id="CIT0096"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Larson</surname><given-names>DE</given-names></name><etal/></person-group><article-title>CMDS: a population-based method for identifying recurrent DNA copy number aberrations in cancer from high-resolution data</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>464</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20031968</pub-id></element-citation></ref><ref id="CIT0097"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Dyk</surname><given-names>E</given-names></name><name><surname>Reinders</surname><given-names>MJ</given-names></name><name><surname>Wessels</surname><given-names>LF</given-names></name></person-group><article-title>A scale-space method for detecting recurrent DNA copy number changes with analytical false discovery rate control</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>e100</fpage><pub-id pub-id-type="pmid">23476020</pub-id></element-citation></ref><ref id="CIT0098"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Henikoff</surname><given-names>S</given-names></name><name><surname>Ng</surname><given-names>PC</given-names></name></person-group><article-title>Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm</article-title><source>Nat Protoc</source><year>2009</year><volume>4</volume><fpage>1073</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">19561590</pub-id></element-citation></ref><ref id="CIT0099"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adzhubei</surname><given-names>IA</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Peshkin</surname><given-names>L</given-names></name><name><surname>Ramensky</surname><given-names>VE</given-names></name><name><surname>Gerasimova</surname><given-names>A</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Kondrashov</surname><given-names>AS</given-names></name><name><surname>Sunyaev</surname><given-names>SR</given-names></name></person-group><article-title>A method and server for predicting damaging missense mutations</article-title><source>Nat Methods</source><year>2010</year><volume>7</volume><fpage>248</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20354512</pub-id></element-citation></ref><ref id="CIT0100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reva</surname><given-names>B</given-names></name><name><surname>Antipin</surname><given-names>Y</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name></person-group><article-title>Predicting the functional impact of protein mutations: application to cancer genomics</article-title><source>Nucleic Acids Res</source><year>2011</year><volume>39</volume><fpage>e118</fpage><pub-id pub-id-type="pmid">21727090</pub-id></element-citation></ref><ref id="CIT0101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Isik</surname><given-names>L</given-names></name><name><surname>Tyekucheva</surname><given-names>S</given-names></name><name><surname>Velculescu</surname><given-names>VE</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Karchin</surname><given-names>R</given-names></name></person-group><article-title>Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations</article-title><source>Cancer Res</source><year>2009</year><volume>69</volume><fpage>6660</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">19654296</pub-id></element-citation></ref><ref id="CIT0102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Pavlicek</surname><given-names>A</given-names></name><name><surname>Lunney</surname><given-names>EA</given-names></name><name><surname>Rejto</surname><given-names>PA</given-names></name><name><surname>Teng</surname><given-names>CH</given-names></name></person-group><article-title>Statistical method on nonrandom clustering with application to somatic mutations in cancer</article-title><source>BMC Bioinformatics</source><year>2010</year><volume>11</volume><fpage>11</fpage><pub-id pub-id-type="pmid">20053295</pub-id></element-citation></ref><ref id="CIT0103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodis</surname><given-names>E</given-names></name><name><surname>Watson</surname><given-names>IR</given-names></name><name><surname>Kryukov</surname><given-names>GV</given-names></name><etal/></person-group><article-title>A landscape of driver mutations in melanoma</article-title><source>Cell</source><year>2012</year><volume>150</volume><fpage>251</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">22817889</pub-id></element-citation></ref><ref id="CIT0104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryslik</surname><given-names>GA</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Cheung</surname><given-names>KH</given-names></name><name><surname>Modis</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name></person-group><article-title>Utilizing protein structure to identify non-random somatic mutations</article-title><source>BMC Bioinformatics</source><year>2013</year><volume>14</volume><fpage>190</fpage><pub-id pub-id-type="pmid">23758891</pub-id></element-citation></ref><ref id="CIT0105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><etal/></person-group><article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><fpage>15545</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="CIT0106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wendl</surname><given-names>MC</given-names></name><name><surname>Wallis</surname><given-names>JW</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Kandoth</surname><given-names>C</given-names></name><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Wilson</surname><given-names>RK</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name></person-group><article-title>PathScan: a tool for discerning mutational significance in groups of putative cancer genes</article-title><source>Bioinformatics</source><year>2011</year><volume>27</volume><fpage>1595</fpage><lpage>602</lpage><pub-id pub-id-type="pmid">21498403</pub-id></element-citation></ref><ref id="CIT0107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boca</surname><given-names>SM</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><name><surname>Velculescu</surname><given-names>VE</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Parmigiani</surname><given-names>G</given-names></name></person-group><article-title>Patient-oriented gene set analysis for cancer mutation data</article-title><source>Genome Biol</source><year>2010</year><volume>11</volume><fpage>R112</fpage><pub-id pub-id-type="pmid">21092299</pub-id></element-citation></ref><ref id="CIT0108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerami</surname><given-names>E</given-names></name><name><surname>Demir</surname><given-names>E</given-names></name><name><surname>Schultz</surname><given-names>N</given-names></name><name><surname>Taylor</surname><given-names>BS</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name></person-group><article-title>Automated network analysis identifies core pathways in glioblastoma</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><fpage>e8918</fpage><pub-id pub-id-type="pmid">20169195</pub-id></element-citation></ref><ref id="CIT0109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandin</surname><given-names>F</given-names></name><name><surname>Upfal</surname><given-names>E</given-names></name><name><surname>Raphael</surname><given-names>BJ</given-names></name></person-group><article-title>Algorithms for detecting significantly mutated pathways in cancer</article-title><source>J Comput Biol</source><year>2011</year><volume>18</volume><fpage>507</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">21385051</pub-id></element-citation></ref><ref id="CIT0110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciriello</surname><given-names>G</given-names></name><name><surname>Cerami</surname><given-names>E</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name><name><surname>Schultz</surname><given-names>N</given-names></name></person-group><article-title>Mutual exclusivity analysis identifies oncogenic network modules</article-title><source>Genome Res</source><year>2012</year><volume>22</volume><fpage>398</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">21908773</pub-id></element-citation></ref><ref id="CIT0111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leiserson</surname><given-names>MD</given-names></name><name><surname>Blokh</surname><given-names>D</given-names></name><name><surname>Sharan</surname><given-names>R</given-names></name><name><surname>Raphael</surname><given-names>BJ</given-names></name></person-group><article-title>Simultaneous identification of multiple driver pathways in cancer</article-title><source>PLoS Comput Biol</source><year>2013</year><volume>9</volume><fpage>e1003054</fpage><pub-id pub-id-type="pmid">23717195</pub-id></element-citation></ref><ref id="CIT0112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>CA</given-names></name><name><surname>Settle</surname><given-names>SH</given-names></name><name><surname>Sulman</surname><given-names>EP</given-names></name><name><surname>Aldape</surname><given-names>KD</given-names></name><name><surname>Milosavljevic</surname><given-names>A</given-names></name></person-group><article-title>Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors</article-title><source>BMC Med Genomics</source><year>2011</year><volume>4</volume><fpage>34</fpage><pub-id pub-id-type="pmid">21489305</pub-id></element-citation></ref><ref id="CIT0113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartram</surname><given-names>CR</given-names></name><name><surname>de Klein</surname><given-names>A</given-names></name><name><surname>Hagemeijer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia</article-title><source>Nature</source><year>1983</year><volume>306</volume><fpage>277</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">6580527</pub-id></element-citation></ref><ref id="CIT0114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soda</surname><given-names>M</given-names></name><name><surname>Choi</surname><given-names>YL</given-names></name><name><surname>Enomoto</surname><given-names>M</given-names></name><etal/></person-group><article-title>Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer</article-title><source>Nature</source><year>2007</year><volume>448</volume><fpage>561</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17625570</pub-id></element-citation></ref><ref id="CIT0115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomlins</surname><given-names>SA</given-names></name><name><surname>Rhodes</surname><given-names>DR</given-names></name><name><surname>Perner</surname><given-names>S</given-names></name><etal/></person-group><article-title>Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer</article-title><source>Science</source><year>2005</year><volume>310</volume><fpage>644</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16254181</pub-id></element-citation></ref><ref id="CIT0116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohno</surname><given-names>T</given-names></name><name><surname>Ichikawa</surname><given-names>H</given-names></name><name><surname>Totoki</surname><given-names>Y</given-names></name><etal/></person-group><article-title>KIF5B-RET fusions in lung adenocarcinoma</article-title><source>Nat Med</source><year>2012</year><volume>18</volume><fpage>375</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22327624</pub-id></element-citation></ref><ref id="CIT0117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgren</surname><given-names>H</given-names></name><name><surname>Murumagi</surname><given-names>A</given-names></name><name><surname>Kangaspeska</surname><given-names>S</given-names></name><etal/></person-group><article-title>Identification of fusion genes in breast cancer by paired-end RNA-sequencing</article-title><source>Genome Biol</source><year>2011</year><volume>12</volume><fpage>R6</fpage><pub-id pub-id-type="pmid">21247443</pub-id></element-citation></ref><ref id="CIT0118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gridelli</surname><given-names>C</given-names></name><name><surname>Peters</surname><given-names>S</given-names></name><name><surname>Sgambato</surname><given-names>A</given-names></name><name><surname>Casaluce</surname><given-names>F</given-names></name><name><surname>Adjei</surname><given-names>AA</given-names></name><name><surname>Ciardiello</surname><given-names>F</given-names></name></person-group><article-title>ALK inhibitors in the treatment of advanced NSCLC</article-title><source>Cancer Treat Rev</source><year>2014</year><volume>40</volume><fpage>300</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">23931927</pub-id></element-citation></ref><ref id="CIT0119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>TJ</given-names></name><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><etal/></person-group><article-title>DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome</article-title><source>Nature</source><year>2008</year><volume>456</volume><fpage>66</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">18987736</pub-id></element-citation></ref><ref id="CIT0120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maher</surname><given-names>CA</given-names></name><name><surname>Kumar-Sinha</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><etal/></person-group><article-title>Transcriptome sequencing to detect gene fusions in cancer</article-title><source>Nature</source><year>2009</year><volume>458</volume><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">19136943</pub-id></element-citation></ref><ref id="CIT0121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Caballero</surname><given-names>OL</given-names></name><name><surname>Levy</surname><given-names>S</given-names></name><etal/></person-group><article-title>Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line</article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><fpage>1886</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">19181860</pub-id></element-citation></ref><ref id="CIT0122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Xia</surname><given-names>J</given-names></name><name><surname>Jia</surname><given-names>P</given-names></name><name><surname>Pao</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name></person-group><article-title>Application of next generation sequencing to human gene fusion detection: computational tools, features and perspectives</article-title><source>Brief Bioinform</source><year>2013</year><volume>14</volume><fpage>506</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">22877769</pub-id></element-citation></ref><ref id="CIT0123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Supper</surname><given-names>J</given-names></name><name><surname>Gugenmus</surname><given-names>C</given-names></name><name><surname>Wollnik</surname><given-names>J</given-names></name><etal/></person-group><article-title>Detecting and visualizing gene fusions</article-title><source>Methods</source><year>2013</year><volume>59</volume><fpage>S24</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23036331</pub-id></element-citation></ref><ref id="CIT0124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biankin</surname><given-names>AV</given-names></name><name><surname>Waddell</surname><given-names>N</given-names></name><name><surname>Kassahn</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes</article-title><source>Nature</source><year>2012</year><volume>491</volume><fpage>399</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">23103869</pub-id></element-citation></ref><ref id="CIT0125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paweletz</surname><given-names>CP</given-names></name><name><surname>Liotta</surname><given-names>LA</given-names></name><name><surname>Petricoin</surname><given-names>EF</given-names><suffix>3rd</suffix></name></person-group><article-title>New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics</article-title><source>Urology</source><year>2001</year><volume>57</volume><fpage>160</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">11295617</pub-id></element-citation></ref><ref id="CIT0126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>VK</given-names></name><name><surname>De</surname><given-names>S</given-names></name></person-group><article-title>An assessment of computational methods for estimating purity and clonality using genomic data derived from heterogeneous tumor tissue samples</article-title><source>Brief Bioinform</source><year>2014</year><comment>[Epub]</comment></element-citation></ref><ref id="CIT0127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>R</given-names></name><name><surname>Mo</surname><given-names>Q</given-names></name><name><surname>Schultz</surname><given-names>N</given-names></name><name><surname>Seshan</surname><given-names>VE</given-names></name><name><surname>Olshen</surname><given-names>AB</given-names></name><name><surname>Huse</surname><given-names>J</given-names></name><name><surname>Ladanyi</surname><given-names>M</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name></person-group><article-title>Integrative subtype discovery in glioblastoma using iCluster</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e35236</fpage><pub-id pub-id-type="pmid">22539962</pub-id></element-citation></ref><ref id="CIT0128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Shah</surname><given-names>PK</given-names></name><name><surname>Amin</surname><given-names>SB</given-names></name><etal/></person-group><article-title>Integrative analysis of gene and miRNA expression profiles with transcription factor-miRNA feed-forward loops identifies regulators in human cancers</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><fpage>e135</fpage><pub-id pub-id-type="pmid">22645320</pub-id></element-citation></ref><ref id="CIT0129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barretina</surname><given-names>J</given-names></name><name><surname>Caponigro</surname><given-names>G</given-names></name><name><surname>Stransky</surname><given-names>N</given-names></name><etal/></person-group><article-title>The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity</article-title><source>Nature</source><year>2012</year><volume>483</volume><fpage>603</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22460905</pub-id></element-citation></ref><ref id="CIT0130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garnett</surname><given-names>MJ</given-names></name><name><surname>Edelman</surname><given-names>EJ</given-names></name><name><surname>Heidorn</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Systematic identification of genomic markers of drug sensitivity in cancer cells</article-title><source>Nature</source><year>2012</year><volume>483</volume><fpage>570</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">22460902</pub-id></element-citation></ref><ref id="CIT0131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerami</surname><given-names>E</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Dogrusoz</surname><given-names>U</given-names></name><etal/></person-group><article-title>The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data</article-title><source>Cancer Discov</source><year>2012</year><volume>2</volume><fpage>401</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">22588877</pub-id></element-citation></ref><ref id="CIT0132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samur</surname><given-names>MK</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Cao</surname><given-names>Q</given-names></name><name><surname>Munshi</surname><given-names>NC</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Shah</surname><given-names>PK</given-names></name></person-group><article-title>canEvolve: a web portal for integrative oncogenomics</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e56228</fpage><pub-id pub-id-type="pmid">23418540</pub-id></element-citation></ref><ref id="CIT0133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>L</given-names></name><name><surname>Hahn</surname><given-names>WC</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name></person-group><article-title>Making sense of cancer genomic data</article-title><source>Genes Dev</source><year>2011</year><volume>25</volume><fpage>534</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">21406553</pub-id></element-citation></ref></ref-list></back></article>